UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



Form 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) ~~OF THE SECURITIES EXCHANGE ACT OF 1934~~

~~For~~OF ~~the~~THE ~~quarterly~~SECURITIES ~~period~~EXCHANGE ~~ended~~ACT ~~September~~OF ~~30, 2025~~1934

For the quarterly period ended March 31, 2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

Commission File Number: 001-39443



NETSTREIT Corp.

(Exact name of registrant as specified in its charter)

Maryland

84-3356606

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

2021 McKinney Avenue

Suite 1150

Dallas, Texas

75201

(Address of principal executive offices)

(Zip Code)

(972) 200-7100

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common stock, par value $0.01 per share

NTST

The New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined byin Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The number of shares of the issuer’s common stock, par value $0.01, outstanding as of ~~October 23~~April 14, ~~2025~~2026 was 8397,~~561~~260,~~676~~607.

NETSTREIT CORP. AND SUBSIDIARIES

TABLE OF CONTENTS

		Page
	PART I — FINANCIAL INFORMATION
Item 1.	Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets as of September 30, 2025 and December 31, 2024	3
	Condensed Consolidated Balance Sheets as of March 31, 2026 and December 31, 2025	3
	Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended September 30, 2025 and 2024	4
	Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three Months Ended March 31, 2026 and 2025	4
	Condensed Consolidated Statements of Changes in Equity for the Three and Nine Months Ended September 30, 2025 and 2024	5
	Condensed Consolidated Statements of Changes in Equity for the Three Months Ended March 31, 2026 and 2025	5
	Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024	7
	Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2026 and 2025	6
	Notes to the Condensed Consolidated Financial Statements	87
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3130
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4642
Item 4.	Controls and Procedures	4743
	PART II – OTHER INFORMATION
Item 1.	Legal Proceedings	4844
Item 1A.	Risk Factors	4844
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	4844
Item 3.	Defaults Upon Senior Securities	4844
Item 4.	Mine Safety Disclosures	4844
Item 5.	Other Information	4844
Item 6.	Exhibits	4945
	Signatures	5046

Table of Contents

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

	September 30, 2025		December 31, 2024
	March 31, 2026		December 31, 2025
Assets
Real estate, at cost:
Land	$	~~676~~857,~~664~~293	$	~~571~~772,~~272~~417
Buildings and improvements	1,~~471~~695,~~002~~969		1,~~400~~590,~~393~~714
Total real estate, at cost	2,~~147~~553,~~666~~262		12,~~971~~363,~~665~~131
Less accumulated depreciation	(~~173~~205,~~846~~787)		(~~143~~188,~~422~~858)
Property under development	110,~~794~~880		65,~~118~~500
Real estate held for investment, net	12,~~975~~358,~~614~~355		12,~~834~~179,~~361~~773
Assets held for sale	8657,~~060~~692		4840,~~637~~976
Mortgage loans receivable, net	~~138~~130,~~307~~325		~~139~~142,~~409~~464
Cash, cash equivalents, and restricted cash	5311,~~324~~058		14,~~320~~467
Lease intangible assets, net	~~157~~181,~~671~~632		~~164~~173,~~392~~440
Other assets, net	5670,~~958~~766		5863,~~227~~076
Total assets	$	2,~~467~~809,~~934~~828	$	2,~~259~~614,~~346~~196
Liabilities and equity
Liabilities:
Term loans, net	$	1,~~092~~143,~~746~~284	$	~~622~~1,~~608~~093,331
Revolving credit facility	—88,000		~~239,000~~—
Mortgage note payable, net	7,~~824~~801		7,~~853~~814
Lease intangible liabilities, net	1716,~~522~~290		2016,~~177~~910
Liabilities related to assets held for sale	1,~~954~~029		1,~~912~~016
Accounts payable, accrued expenses, and other liabilities	4142,~~957~~003		2942,~~664~~559
Total liabilities	1,~~162~~298,~~003~~407		~~921~~1,~~214~~161,630
Commitments and contingencies (Note 13)
Equity:
Stockholders’ equity
Common stock, $0.01 par value, 400,000,000 shares authorized; 83,479,176 and 81,602,232 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively	835		816
Common stock, $0.01 par value, 400,000,000 shares authorized; 97,253,523 and 93,070,533 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	973		931
Additional paid-in capital	1,~~540~~769,~~070~~473		1,~~507~~701,~~995~~572
Distributions in excess of retained earnings	(~~235~~267,~~097~~741)		(~~188~~251,~~046~~926)
Accumulated other comprehensive (loss) income	(6,619)		10,206
Accumulated other comprehensive income (loss)	2,384		(4,565)
Total stockholders’ equity	1,~~299~~505,~~189~~089		1,~~330~~446,~~971~~012
Noncontrolling interests	6,~~742~~332		76,~~161~~554
Total equity	1,~~305~~511,~~931~~421		1,~~338~~452,~~132~~566
Total liabilities and equity	$	2,~~467~~809,~~934~~828	$	2,~~259~~614,~~346~~196

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(In thousands, except share and per share data)

(Unaudited)

	Three Months EndedSeptember 30,				Nine Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2025		2024		2025		2024
	2026		2025
Revenues
Rental revenue (including reimbursable)	$	4554,~~026~~027	$	3842,~~172~~590	$	~~132,774~~	$	~~110,226~~
Interest income on loans receivable	3,~~282~~035		3,~~272~~075		~~9,485~~		~~8,458~~
Other revenue	—		—245		~~245~~		—
Total revenues	4857,~~308~~062		4145,~~444~~910		~~142,504~~		~~118,684~~
Operating expenses
Property	45,~~302~~404		4,~~494~~803		~~13,589~~		~~12,578~~
General and administrative	5,~~128~~755		45,~~287~~169		~~15,772~~		~~15,266~~
Depreciation and amortization	2124,~~389~~463		20,~~438~~923		~~63,818~~		~~56,522~~
Provisions for impairment	52,~~493~~062		93,~~838~~616		~~13,531~~		~~17,336~~
Transaction costs	19		26		139		201
Transaction costs, net	(60)		47
Total operating expenses	3637,~~331~~624		3934,~~083~~558		~~106,849~~		~~101,903~~
Other (expense) income
Interest expense, net	(1214,~~636~~266)		(711,~~965~~460)		~~(36,734)~~		~~(21,749)~~
Gain (loss) on sales of real estate, net	1,122		(132)		6,730		874
Gain on sales of real estate, net	119		2,075
Loss on debt extinguishment	—		—(46)		~~(46)~~		—
Other income (expense), net	~~170~~434		~~416~~(205)		46		~~(2,451)~~
Total other expense, net	(1113,~~344~~713)		(79,~~681~~636)		~~(30,004)~~		~~(23,326)~~
Net income (loss) before income taxes	633		(5,320)		5,651		(6,545)
Net income before income taxes	5,725		1,716
Income tax expense	(1214)		(216)		~~(41)~~		~~(31)~~
Net income (loss)	621		(5,322)		5,610		(6,576)
Net income	5,711		1,700
Net income (loss) attributable to noncontrolling interests	3		(27)		29		(35)
Net income attributable to noncontrolling interests	24		9
Net income (loss) income attributable to common stockholders	$	618	$	(5,295)	$	5,581	$	(6,541)
Net income attributable to common stockholders	$	5,687	$	1,691
Amounts available to common stockholders per common share:
Basic	$	0.0106	$	(0.~~07)~~02	$	~~0.07~~	$	~~(0.09)~~
Diluted	$	0.0106	$	(0.~~07)~~02	$	~~0.07~~	$	~~(0.09)~~
Weighted average common shares:
Basic	8395,~~472~~543,~~089~~920		7781,~~610~~644,~~680~~492		~~82,344,168~~		~~74,822,286~~
Diluted	8599,~~641~~107,~~948~~642		7782,~~610~~132,~~680~~524		~~83,429,550~~		~~74,822,286~~
Other comprehensive loss:
Other comprehensive income (loss):
Net income (loss)	$	621	$	(5,322)	$	5,610	$	(6,576)
Net income	$	5,711	$	1,700
Change in value of derivatives, net	(1,404)		(20,164)		(16,912)		(11,456)
Change in value on derivatives, net	6,978		(9,864)
Total comprehensive loss	$	(783)	$	(25,486)	$	(11,302)	$	(18,032)
Total comprehensive income (loss)	$	12,689	$	(8,164)
Comprehensive loss attributable to noncontrolling interests	(4)		(138)		(58)		(95)
Comprehensive income (loss) attributable to noncontrolling interests	53		(42)
Comprehensive loss attributable to common stockholders	$	(779)	$	(25,348)	$	(11,244)	$	(17,937)
Comprehensive income (loss) attributable to common stockholders	$	12,636	$	(8,122)

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands, except share data)

(Unaudited)

	Common stock
	Shares	Par Value		Additional Paid-in Capital		Distributions in Excess of Retained Earnings		Accumulated Other Comprehensive Income ~~(Loss)~~		Total Stockholders’ Equity		Noncontrolling Interests		Total Equity
Balance at December 31, 2024	81,602,232	$	816	$	1,507,995	$	(188,046)	$	10,206	$	1,330,971	$	7,161	$	1,338,132
Balance at December 31, 2025	93,070,533	$	931	$	1,701,572	$	(251,926)	$	(4,565)	$	1,446,012	$	6,554	$	1,452,566
Dividends and distributions declared on common stock and OP Units	—	—		—		(17,157)		—		(17,157)		(89)		(17,246)
Issuance of common stock in public offerings, net of issuance costs	4,000,000	40		67,753		—		—		67,793		—		67,793
Dividends declared on restricted stock, net	—	—		—		(181)		—		(181)		—		(181)
OP Units converted to common stock	9,965	—		158		—		—		158		(158)		—
Vesting of restricted stock units	136,338	1		(1)		—		—		—		—		—
Dividends and distributions declared on common stock and OP Units	—	—		—		(21,396)		—		(21,396)		(117)		(21,513)
Repurchase of common stock for tax withholding obligations	(39,661)	—		(573)		—		—		(573)		—		(573)
Dividends declared on restricted stock, net	—	—		—		(150)		—		(150)		—		(150)
Stock-based compensation, net	—	—		1,388		169		—		1,557		—		1,557
Vesting of restricted stock units	255,868	3		(3)		—		—		—		—		—
Other comprehensive loss	—	—		—		—		(9,813)		(9,813)		(51)		(9,864)
Repurchase of common stock for tax withholding obligations	(82,843)	(1)		(1,696)		—		—		(1,697)		—		(1,697)
Net income	—	—		—		1,691		—		1,691		9		1,700
Stock-based compensation, net	—	—		1,689		44		—		1,733		—		1,733
Balance at March 31, 2025	81,698,909	$	817	$	1,508,809	$	(203,524)	$	393	$	1,306,495	$	7,030	$	1,313,525
Other comprehensive income	—	—		—		—		6,949		6,949		29		6,978
Issuance of common stock in public offerings, net of issuance costs	1,757,815	18		28,334		—		—		28,352		—		28,352
Net income	—	—		—		5,687		—		5,687		24		5,711
Dividends and distributions declared on common stock and OP Units	—	—		—		(17,159)		—		(17,159)		(89)		(17,248)
Balance at March 31, 2026	97,253,523	$	973	$	1,769,473	$	(267,741)	$	2,384	$	1,505,089	$	6,332	$	1,511,421
Dividends declared on restricted stock, net	—	—		—		(178)		—		(178)		—		(178)
Vesting of restricted stock units	13,096	—		—		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(4,769)	—		(72)		—		—		(72)		—		(72)
Stock-based compensation, net	—	—		1,521		—		—		1,521		—		1,521
Other comprehensive loss	—	—		—		—		(5,615)		(5,615)		(29)		(5,644)
Net income	—	—		—		3,272		—		3,272		17		3,289
Balance at June 30, 2025	83,465,051	$	835	$	1,538,592	$	(217,589)	$	(5,222)	$	1,316,616	$	6,929	$	1,323,545
OP Units converted to common stock	5,694	—		92		—		—		92		(92)		—
Dividends and distributions declared on common stock and OP Units	—	—		—		(17,947)		—		(17,947)		(91)		(18,038)
Dividends declared on restricted stock, net	—	—		—		(179)		—		(179)		—		(179)
Vesting of restricted stock units	13,678	—		—		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(5,247)	—		(98)		—		—		(98)		—		(98)
Stock-based compensation, net	—	—		1,484		—		—		1,484		—		1,484
Other comprehensive loss	—	—		—		—		(1,397)		(1,397)		(7)		(1,404)
Net income	—	—		—		618		—		618		3		621
Balance at September 30, 2025	83,479,176	$	835	$	1,540,070	$	(235,097)	$	(6,619)	$	1,299,189	$	6,742	$	1,305,931


	Common stock
	Shares	Par Value		Additional Paid-in Capital		Distributions in Excess of Retained Earnings		Accumulated Other Comprehensive Income		Total Stockholders’ Equity		Noncontrolling Interests		Total Equity
Balance at December 31, 2024	81,602,232	$	816	$	1,507,995	$	(188,046)	$	10,206	$	1,330,971	$	7,161	$	1,338,132


Dividends and distributions declared on common stock and OP Units	—	—		—		(17,157)		—		(17,157)		(89)		(17,246)
Dividends declared on restricted stock, net	—	—		—		(181)		—		(181)		—		(181)
Vesting of restricted stock units	136,338	1		(1)		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(39,661)	—		(573)		—		—		(573)		—		(573)
Stock-based compensation, net	—	—		1,388		169		—		1,557		—		1,557
Other comprehensive loss	—	—		—		—		(9,813)		(9,813)		(51)		(9,864)
Net income	—	—		—		1,691		—		1,691		9		1,700
Balance at March 31, 2025	81,698,909	$	817	$	1,508,809	$	(203,524)	$	393	$	1,306,495	$	7,030	$	1,313,525

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY

(In thousands, except share data)

(Unaudited)

	Common stock
	Shares	Par Value		Additional Paid-in Capital		Distributions in Excess of Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Total Stockholders’ Equity		Noncontrolling Interests		Total Equity
Balance at December 31, 2023	73,207,080	$	732	$	1,367,505	$	(112,276)	$	8,943	$	1,264,904	$	8,528	$	1,273,432
OP Units converted to common stock	7,119	—		126		—		—		126		(126)		—
Dividends and distributions declared on common stock and OP Units	—	—		—		(15,031)		—		(15,031)		(98)		(15,129)
Dividends declared on restricted stock, net	—	—		—		(143)		—		(143)		—		(143)
Vesting of restricted stock units	176,197	2		(2)		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(61,985)	(1)		(1,068)		—		—		(1,069)		—		(1,069)
Stock-based compensation, net	—	—		1,751		135		—		1,886		—		1,886
Other comprehensive income	—	—		—		—		9,077		9,077		51		9,128
Net income	—	—		—		1,045		—		1,045		7		1,052
Balance at March 31, 2024	73,328,411	$	733	$	1,368,312	$	(126,270)	$	18,020	$	1,260,795	$	8,362	$	1,269,157
Issuance of common stock in public offerings, net of issuance costs	4,000,000	40		65,284		—		—		65,324		—		65,324
OP Units converted to common stock	35,121	—		611		—		—		611		(611)		—
Dividends and distributions declared on common stock and OP Units	—	—		—		(15,042)		—		(15,042)		(90)		(15,132)
Dividends declared on restricted stock, net	—	—		—		(139)		—		(139)		—		(139)
Vesting of restricted stock units	23,510	—		—		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(9,363)	—		(160)		—		—		(160)		—		(160)
Stock-based compensation, net	—	—		1,530		8		—		1,538		—		1,538
Other comprehensive loss	—	—		—		—		(420)		(420)		—		(420)
Net loss	—	—		—		(2,291)		—		(2,291)		(15)		(2,306)
Balance at June 30, 2024	77,377,679	$	773	$	1,435,577	$	(143,734)	$	17,600	$	1,310,216	$	7,646	$	1,317,862
Issuance of common stock in public offerings, net of issuance costs	4,183,711	43		70,109		—		—		70,152		—		70,152
OP Units converted to common stock	12,102	—		204		—		—		204		(204)		—
Dividends and distributions declared on common stock and OP Units	—	—		—		(16,251)		—		(16,251)		(92)		(16,343)
Dividends declared on restricted stock, net	—	—		—		(141)		—		(141)		—		(141)
Vesting of restricted stock units	16,455	—		—		—		—		—		—		—
Repurchase of common stock for tax withholding obligations	(6,030)	—		(96)		—		—		(96)		—		(96)
Stock-based compensation, net	—	—		1,376		—		—		1,376		—		1,376
Other comprehensive loss	—	—		—		—		(20,053)		(20,053)		(111)		(20,164)
Net loss	—	—		—		(5,295)		—		(5,295)		(27)		(5,322)
Balance at September 30, 2024	81,583,917	$	816	$	1,507,170	$	(165,421)	$	(2,453)	$	1,340,112	$	7,212	$	1,347,324

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NETSTREIT CORP. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Nine Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2025		2024
	2026		2025
Cash flows from operating activities
Net income (loss)	$	5,610	$	(6,576)
Net income	$	5,711	$	1,700
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	6324,~~818~~463		5620,~~522~~923
Amortization of deferred financing costs	~~2,164~~971		~~1,673~~664
Amortization of above/below-market assumed debt	8629		8629
Noncash revenue adjustments	(32,~~473~~212)		(21,~~378~~028)
Amortization of deferred losses (gains) on interest rate swaps	~~2,138~~705		~~(2,948)~~705
Stock-based compensation expense	41,~~393~~689		41,~~657~~388
Gain on sales of real estate, net	(~~6,730~~119)		(~~874~~2,075)
Provisions for impairment	132,~~531~~062		173,~~336~~616
Loss on debt extinguishment	46—		—46
(Gain) loss on involuntary conversion of building and improvements	(45)		644
Changes in assets and liabilities, net of assets acquired and liabilities assumed:
Other assets, net	(~~775~~8,265)		(43,~~019~~770)
Accounts payable, accrued expenses, and other liabilities	~~402~~1,278		~~(1,973)~~92
Lease incentive payments	~~(464)~~—		(22199)
Net cash provided by operating activities	8026,~~701~~312		6222,~~128~~091
Cash flows from investing activities
Acquisitions of real estate	(~~365~~233,~~223~~695)		(~~302~~77,~~299~~468)
Real estate development and improvements	(45,~~041~~713)		(372,~~306~~810)
Investment in mortgage loans receivable	(265,~~726~~091)		(2610,~~205~~462)
Earnest money deposits	~~(382)~~5,595		(~~7,925~~875)
Purchase of computer equipment and other corporate assets	~~(35)~~—		(811)
Proceeds from sale of real estate	~~121~~10,~~719~~391		4238,~~845~~563
Principal collections on mortgage loans receivable	2411,~~655~~234		114,~~258~~755
Proceeds from sale of mortgage loans receivable	105,~~480~~587		—
Proceeds from the settlement of property-related insurance claims	45		261
Net cash used in investing activities	(211,692)		(48,308)
Net cash used in investing activities	(239,508)		(319,379)
Cash flows from financing activities
Issuance of common stock in public offerings, net	2867,~~352~~793		~~135,475~~—
Payment of common stock dividends	(5221,~~263~~396)		(4617,~~324~~157)
Payment of OP unit distributions	(~~269~~106)		(~~280~~89)
Payment of restricted stock dividends	(~~274~~392)		(~~491~~199)
Principal payments on mortgages payable	(~~122~~43)		(~~115~~41)
Proceeds under revolving credit facilities	199,000		251,000
Proceeds under revolving credit facility	98,000		89,500
Repayments under revolving credit facilities	(438,000)		(181,000)
Repayments under revolving credit facility	(10,000)		(214,000)
Proceeds from term loans	~~518~~50,~~675~~000		~~100~~218,~~000~~675
Principal payments on term loans	~~(43,675)~~—		—(43,675)
Repurchase of common stock for tax withholding obligations	(~~743~~1,697)		(~~1,325~~573)
Payment of deferred offering costs	(~~835~~188)		(~~868~~60)
Payment of deferred financing costs	~~(12,035)~~—		—(6,279)
Net cash provided by financing activities	~~197~~181,~~811~~971		~~256~~26,~~072~~102
Net change in cash, cash equivalents, and restricted cash	39(3,~~004~~409)		(~~1,179~~115)
Cash, cash equivalents, and restricted cash at beginning of the period	14,~~320~~467		2914,~~929~~320
Cash, cash equivalents, and restricted cash at end of the period	$	5311,~~324~~058	$	2814,~~750~~205
Supplemental disclosures of cash flow information:
Cash paid for interest, net of amounts capitalized	$	3112,~~894~~722	$	2210,~~778~~005
Cash (received) paid for income taxes, net	$	(3)	$	27
Supplemental disclosures of non-cash investing and financing activities:
Dividends declared and unpaid on restricted stock	$	368	$	279
Dividends declared and unpaid, net	$	117	$	12
Deferred offering costs included in accounts payable, accrued expenses, and other liabilities	$	16502	$	~~318~~24
Accrued loan origination fees on mortgage loans receivable	$	~~188~~34	$	~~200~~—
Cash flow hedge change in fair value	$	~~(19~~6,~~050)~~273	$	(810,~~508~~569)
Increase in mortgage loan receivable in exchange for disposition of real estate	$	8,450	$	12,714
Assumption of tenant allowances, other liabilities, and settlement of receivables in acquisitions of real estate	$	279	$	6
Assumption of tenant allowances, other liabilities, and settlement of receivables in acquisitions of real estate	$	3,068	$	1,007
Accrued capital expenditures and real estate development and improvement costs	$	1,139	$	600
Accrued capital expenditures and real estate development and improvement costs	$	2,025	$	3,963

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NETSTREIT CORP. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1 – Organization and Description of Business

NETSTREIT Corp. (the “Company”) was incorporated on October 11, 2019 as a Maryland corporation and commenced operations on December 23, 2019. The Company conducts its operations through NETSTREIT, L.P., a Delaware limited partnership (the “Operating Partnership”). NETSTREIT GP, LLC, a Delaware limited liability company and a wholly owned subsidiary of the Company, is the sole general partner of the Operating Partnership.

The Company elected to be treated as and to qualify as a real estate investment trust (“REIT”) for U.S. federal income tax purposes beginning with its short taxable year ended December 31, 2019. Additionally, the Operating Partnership formed NETSTREIT Management TRS, LLC (“NETSTREIT TRS”), which together with the Company jointly elected to be treated as a taxable REIT subsidiary under Section 856(a) of the Internal Revenue Code of 1986, as amended, (the “Code”) for U.S. federal income tax purposes.

The Company is structured as an umbrella partnership real estate investment trust (commonly referred to as an “UPREIT”) and is an internally managed real estate company that acquires, owns, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. The Company also invests in property developments and mortgage loans secured by real estate. As of ~~September~~March 3031, ~~2025~~2026, the Company owned or had investments in ~~723~~808 properties located in 4546 states.

Note 2 – Summary of Significant Accounting Policies

Basis of Presentation

The accompanying interim condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). The accompanying condensed consolidated financial statements include the accounts of the Company and subsidiaries in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation and the Company’s net income ~~(loss)~~ is reduced by the portion of net income ~~(loss)~~ attributable to noncontrolling interests.

Interim Unaudited Financial Information

The accompanying unaudited interim condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. These unaudited interim condensed consolidated financial statements do not include all of the information and notes required by GAAP for complete financial statements, and should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto on the Annual Report on Form 10-K as of and for the year ended December 31, ~~2024~~2025, which provide a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. In the opinion of management, all adjustments of a normal recurring nature necessary for a fair presentation have been included. The results of operations for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024~~2025 are not necessarily indicative of the results for the full year.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s most significant assumptions and estimates relate to the useful lives of real estate assets, lease accounting, real estate impairment assessments, and allocation of fair value of purchase consideration. These estimates are based on historical experience and other assumptions which management believes are reasonable under the circumstances. The Company evaluates its estimates on an ongoing basis and makes revisions to these estimates and related disclosures as experience develops or new information becomes known. Actual results could differ from those estimates.

Table of Contents

Provisions for Impairment

Long-Lived Assets

Fair value measurement of an asset group occurs when events or changes in circumstances related to an asset indicate that the carrying amount of the asset is no longer recoverable. An example of an event or changed circumstance is a reduction in the expected holding period of a property. If indicators are present, the Company will prepare a projection of the undiscounted future cash flows of the property, excluding interest charges, and determine if the carrying amount of the asset group is recoverable. When a carrying amount is not recoverable, an impairment loss is recognized to the extent that the carrying amount of the asset group exceeds its fair market value. The Company estimates fair value using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, and discount rates, and with regard to assets held for sale, based on the estimated or negotiated selling price, less estimated costs of disposal. Based on these unobservable inputs, the Company determined that its valuations of impaired real estate and intangible assets fall within Level 3 of the fair value hierarchy under Accounting Standards Codification (“ASC”) Topic 820, Fair Value Measurement (“ASC 820”). The Company recorded provisions for impairment on long-lived assets of $4.1.5 million and $93.86 million during the three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024, respectively, and $12.2 million and $17.3 million during the nine months ended September 30,~~ 2025 ~~and 2024~~, respectively.

Mortgage Loans Receivable, Net

The Company classifies mortgage loans receivable as held for sale when it has made the decision to sell a loan. The Company records provisions for impairment on mortgage loans receivable when classified as held for sale if the amortized cost basis exceeds fair value. Fair value is determined based on Level 3 inputs within the fair value hierarchy under ASC 820, which includes the expected selling price of the loan, current market conditions, investor yield requirements, and other relevant factors. The Company recorded non-credit related provisions for impairment of $10.46 million on ~~three~~one mortgage ~~loans~~loan receivable that ~~were~~was disposed of at a discount during the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026. No provisions for impairment on mortgage loans receivable were recorded during the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2024~~2025.

Cash, Cash Equivalents, and Restricted Cash

The Company considers all cash balances, money market accounts, and highly liquid investments with original maturities of three months or less to be cash and cash equivalents. Restricted cash includes cash restricted for property tenant improvements and cash proceeds from the sale of assets held by qualified intermediaries in anticipation of the acquisition of replacement properties in tax-free exchanges under Section 1031 of the Code. Restricted cash is included in cash, cash equivalents, and restricted cash in the condensed consolidated balance sheets. The Company had ~~no restricted cash as of September 30, 2025 and~~ $70.91 million of restricted cash as of March 31, 2026 and December 31, ~~2024~~2025.

The Company’s bank balances as of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025 included certain amounts over the Federal Deposit Insurance Corporation limits.

Fair Value Measurements

The Company estimates fair value of financial and nonfinancial assets and liabilities based on the framework established in the fair value accounting guidance, ASC ~~Topic~~ 820~~, Fair Value Measurement~~. Fair value measurements are utilized in the accounting of the Company’s assets acquired and liabilities assumed in an asset acquisition and also affect the Company’s accounting for certain of its financial assets and liabilities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). The hierarchy described below prioritizes inputs to the valuation techniques used in measuring the fair value of assets and liabilities. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring the most observable inputs to be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows:

Level 1 — Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.

Level 3 — Unobservable inputs for the asset or liability.

Table of Contents

Concentrations of Credit Risk

During the three ~~and nine~~ months ended ~~September 30~~March 31, 2026 and 2025, there were no tenants or borrowers with rental revenue or interest income on loans receivable that exceeded 10% of total revenues.

During the three and nine months ended September 30, 2024, one tenant, Dollar General, accounted for 11.6% and 12.0% of total revenues, respectively.

Other financial instruments that potentially subject the Company to significant concentrations of credit risk consist of cash held at various financial institutions, access to the Company’s credit facilities, and amounts due or payable under derivative contracts. These credit risk exposures are spread among a diversified group of investment grade financial institutions.

Segment Reporting

ASC Topic 280, Segment Reporting, establishes standards for the manner in which companies report information about operating segments. The Company is an internally managed real estate company that acquires, owns, invests in, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. The Company primarily engages in leasing activities that generate revenues and incur operating expenses in addition to investing in property developments and mortgage loans secured by real estate. The Company aggregates these investments for reporting purposes and operates in one reportable segment.

The Company’s chief operating decision maker (“CODM”) is the Company’s senior executive investment committee that includes the chief executive officer and chief financial officer. The CODM uses net income ~~(loss)~~, as reported on the condensed consolidated statements of operations and comprehensive income (loss) to measure segment operating performance and allocate resources. All of the Company’s expenses are included in segment operating performance and are reviewed regularly. Significant segment expenses include property, general and administrative, depreciation and amortization, provisions for impairment, and interest expense. The measure of segment assets is reported on the Company’s condensed consolidated balance sheets as total assets. The CODM also reviews characteristics of potential future investments such as weighted average remaining lease term (“WALT”), ~~capitalization~~cash ~~rate~~yield, tenant credit quality, industry type, and geographic location.

Recent Accounting Pronouncements

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”). ASU 2023-09 requires annual disclosure of specific categories in the rate reconciliation and provides additional information for reconciling items that meet a quantitative threshold within the rate reconciliation. In addition, the amendments require annual disclosure of income taxes paid disaggregated by federal, state, and foreign jurisdictions as well as individual jurisdictions in which income taxes paid is equal to or greater than five percent of total income taxes paid. ASU 2023-09 is effective for annual periods beginning after December 15, 2024 on a prospective basis, however early adoption and retrospective application is permitted. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”). ASU 2024-03 requires disclosure, in the notes to the financial statements, of specified information about certain costs and expenses and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. ASU 2024-03 is effective for annual periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

In November 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements (“ASU 2025-09”). ASU 2025-09 expands eligibility of risk components for hedge designation, clarifies the presentation and disclosure requirements for hedging relationships, and simplifies the assessment of hedge effectiveness. ASU 2025-09 is effective for annual periods beginning after December 15, 2026, including interim periods within those fiscal years. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements (“ASU 2025-11”). ASU 2025-11 is intended to clarify and improve certain aspects of interim financial reporting, including the requirements for interim disclosures and the application of recognition and measurement guidance in interim periods. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The Company is currently evaluating the potential impact of the guidance and potential additional disclosures required.

Note 3 – Leases

Tenant Leases

The Company acquires, owns, and manages single-tenant commercial retail net lease properties, the majority of which have long-term triple-net leases where the tenant is generally responsible for all improvements and contractually obligated to pay all operating costs (such as real estate taxes, utilities, and repairs and maintenance costs). As of ~~September~~March 3031, ~~2025~~2026, exclusive of mortgage loans receivable, the Company’s WALT was 910.92 years.

109

Table of Contents

The Company’s property leases have been classified as operating leases, ~~most~~with ofapproximately ~~which~~half ~~have~~having scheduled rent increases throughout the lease term. The Company’s leases typically provide the tenant one or more multi-year renewal options to extend their leases, subject to generally the same terms and conditions, including rent increases, consistent with the initial lease term.

All lease-related income is reported as a single line item, rental revenue (including reimbursable), in the condensed consolidated statements of operations and comprehensive income (loss) and is presented net of any reserves, write-offs, or recoveries for uncollectible amounts.

Fixed lease income includes stated amounts per the lease contract, which include base rent, fixed common area maintenance charges, and straight-line lease adjustments.

Variable lease income primarily includes recoveries from tenants, which represent amounts that tenants are contractually obligated to reimburse the Company for, specific to their portion of actual recoverable costs incurred. Variable lease income also includes percentage rent, which represents amounts billable to tenants based on their actual sales volume in excess of levels specified in the lease contract.

The following table provides a disaggregation of lease income recognized under ASC Topic 842, Leases (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

Three Months Ended March 31,

2025

2024

2025

2024

2026

2025

Rental revenue

Fixed lease income (1)

4149,~~587~~799

3539,~~346~~092

~~121,854~~

~~101,000~~

Variable lease income (2)

34,~~404~~275

23,~~657~~428

~~10,809~~

~~8,864~~

Other rental revenue:

Above/below market lease amortization, net

~~247~~160

~~354~~262

~~766~~

~~927~~

Lease incentives

(~~212~~207)

(~~185~~192)

~~(655)~~

~~(565)~~

Rental revenue (including reimbursable)

4554,~~026~~027

3842,~~172~~590

~~132,774~~

~~110,226~~

(1) Fixed lease income includes contractual rents under lease agreements with tenants recognized on a straight-line basis over the lease term.

(2) Variable lease income primarily includes tenant reimbursements for real estate taxes, insurance, common area maintenance, and reserves for uncollectible amounts. There were no material reserves, write-offs, or recoveries of uncollectible amounts during the ~~three~~periods ~~and~~indicated ~~nine months ended September 30, 2025 and 2024~~above.

Scheduled future minimum base rental payments (excluding base rental payments from properties classified as held for sale and straight-line rent adjustments for all properties) due to be received under the remaining noncancellable term of the operating leases in place as of ~~September~~March 3031, ~~2025~~2026 are as follows (in thousands):

	Future Minimum BaseRental Receipts
Remainder of 2025	$	41,230
Remainder of 2026	$	150,226
2026	165,266
2027	198,922
2027	163,299
2028	193,560
2028	158,233
2029	184,943
2029	149,465
2030	174,352
Thereafter	1,~~065~~303,~~458~~632
Total	$	12,~~742~~205,~~951~~635

Future minimum rentals exclude amounts that may be received from tenants for reimbursements of operating costs and property taxes. In addition, the future minimum rents do not include any contingent rents based on a percentage of the lessees’ gross sales or lease escalations based on future changes in the Consumer Price Index or other stipulated reference rate.

Table of Contents

Note 4 – Real Estate Investments

As of ~~September~~March 3031, ~~2025~~2026, the Company owned or had investments in ~~723~~808 properties. The gross real estate investment portfolio, including properties under development and mortgage loans receivable, totaled approximately $23.60 billion and consisted of the gross acquisition cost of land, buildings, improvements, lease intangible assets and liabilities, mortgage loans receivable, and property development costs. The investment portfolio is geographically dispersed throughout 4546 states with gross real estate investments in Texas and Illinois representing 1417.65% and 8.41%, respectively, of the total gross real estate investment of the Company’s investment portfolio.

~~The Company’s gross investment portfolio as of September 30, 2025 and December 31, 2024 is summarized below (dollars in thousands):~~10

	Number of Investments		Amount of Investment
	September 30, 2025	December 31, 2024	September 30, 2025		December 31, 2024
Properties held for investment (1)	602	589	$	2,349,144	$	2,164,566
Properties held for sale	39	23	84,106		46,725
Mortgage loans receivable	80	76	138,452		139,483
Properties under development (2)	2	4	1,794		6,118
Total gross investment	723	692	$	2,573,496	$	2,356,892

Table of Contents

~~(1)~~The ~~Includes~~Company’s ~~one~~gross ~~vacant~~investment ~~property~~portfolio ~~for~~is ~~the~~summarized ~~periods~~below ~~ended~~(dollars ~~September 30,~~in ~~2025 and December 31, 2024, and one completed development where rent had not commenced as of December 31, 2024.~~ thousands):


	Number of Investments		Amount of Investment
	March 31, 2026	December 31, 2025	March 31, 2026		December 31, 2025
Properties held for investment (1)	703	656	$	2,790,648	$	2,585,707
Properties held for sale	25	21	56,663		39,960
Mortgage loans receivable	76	81	130,360		142,555
Properties under development (2)	4	3	10,880		5,500
Total gross investment	808	761	$	2,988,551	$	2,773,722

(1) Includes one vacant property for the periods ended March 31, 2026 and December 31, 2025.

(2) Rent has not commenced for properties under development.

Acquisitions

The Company’s acquisitions during the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024~~2025 were all accounted for as asset acquisitions. An allocation of the purchase price and acquisition costs paid for the completed acquisitions during the period is as follows (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
Number of properties acquired	4656		2218		87		68
Purchase price allocation:
Land	$	7693,~~421~~067	$	3121,~~964~~274	$	~~151,504~~	$	~~76,836~~
Buildings	93101,~~726~~115		6445,~~504~~576		~~173,046~~		~~179,391~~
Site improvements	9,~~363~~787		53,~~792~~835		~~16,444~~		~~19,221~~
Tenant improvements	1,~~263~~652		~~801~~525		~~2,112~~		~~2,605~~
In-place lease intangible assets	1216,~~619~~178		96,~~481~~264		~~24,288~~		~~25,253~~
Above-market lease intangible assets	968		—		968		—
Assets held for sale	12,175		—
Below-market lease intangible liabilities	(71)		—		(71)		—
Total (1)	$	233,974	$	77,474
Total (1)	$	194,289	$	112,542	$	368,291	$	303,306

(1) During the three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024~~2025, the Company capitalized $2.3 ~~million and $1~~.10 million ~~of acquisition costs, respectively. During the nine months ended September 30, 2025~~ and ~~2024, the Company capitalized~~ $40.29 million ~~and $2.8 million~~ of acquisition costs, respectively.

Table of Contents

Dispositions

The Company’s property dispositions during the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024~~2025 are summarized below (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
Number of properties sold	245		816		60		26
Sales price, net of disposal costs	$	3510,~~993~~391	$	2338,~~018~~563	$	~~130,169~~	$	~~55,559~~
Gain (loss) on sales of real estate, net	$	1,122	$	(132)	$	6,730	$	874
Gain on sales of real estate, net	$	119	$	2,075

Table of Contents

Development

The Company’s investment in property developments during the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024~~2025 ~~are~~is summarized below (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
Number of developments acquired	—1		—		—		4
Purchase price of acquired developments	$	—2,329	$	—	$	—	$	~~2,010~~
Total investment in properties under development (1)	$	145,380	$	~~4,975~~741	$	~~2,214~~	$	~~27,936~~
Number of developments completed (2)	—		21		2		16
Amounts placed into service (3)	$	—	$	123,~~529~~805	$	~~6,545~~	$	~~47,772~~

(1) During the three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024, the Company capitalized less than $0.1 million and $0.1 million, respectively, of interest expense associated with properties under development. During the nine months ended September 30,~~ 2025 ~~and 2024~~, the Company capitalized ~~approximately~~ $0.1 million ~~and $0.7 million, respectively,~~ of interest expense associated with properties under development.

(2) For the ~~two~~one ~~developments~~development completed during the ~~nine~~three months ended ~~September 30~~March 31, 2025, rent commenced in the second quarter of 2025. ~~For the 16 developments completed during the nine months ended September 30, 2024, rent commenced at various points throughout 2024.~~

(3) Amounts reclassified from property under development to land, buildings and improvements, and other assets (leasing commissions) in the accompanying condensed consolidated balance sheets.

As of ~~September~~March 3031, ~~2025~~2026, the Company had ~~two~~four property developments under construction, which are expected to be substantially completed with rent commencing at various points throughout 2026 and into the first quarter of 2027. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of ~~September~~March 3031, ~~2025~~2026.

Table of Contents

Investment in Mortgage Loans Receivable

The Company’s mortgage loans receivable portfolio ~~as of September 30, 2025 and December 31, 2024~~ is summarized below (dollars in thousands):

Loan Type	Monthly Payment (1)	Number of Secured Properties	Effective Interest Rate (2)	Stated Interest Rate	Maturity Date	~~September~~March 3031, ~~2025~~2026		December 31, ~~2024~~2025
Mortgage (3) (4)	I/O	1	6.9400%	6.00%	8/31/2027	$	38,162	$	4338,~~612~~162
Mortgage (4)	I/O	46	9.55%	9.55%	3/10/2026	41,940		41,940
Mortgage (4) (5)	I/O	46	9.55%	9.55%	3/10/2026	41,940		41,940
Mortgage (4) (5)	I/O	3	8.10%	6.89%	4/10/2026	4,132		4,132
Mortgage (4) (6)	I/O	3	9.68%	8.48%	4/10/2026	4,132		4,132
Mortgage (3) (4) (5)	I/O	2	8.79%	10.09%	6/10/2026	2,230		8,408
Mortgage (3) (4) (6)	I/O	2	17.63%	10.09%	6/10/2026	2,230		2,230
Mortgage	None (67)	1	7.00%	7.00%	5/1/~~31/~~2026	~~825~~725		825
Mortgage (3) (4) (7)	I/O	6	10.26%	10.25%	2/22/2026	11,059		11,658
Mortgage (3) (4)	I/O	5	12.68%	10.25%	9/30/2026	9,356		9,356
Mortgage (3) (4) (8)	I/O	5	10.25%	10.25%	2/27/2026	10,174		8,853
Mortgage (3) (4)	I/O	1	12.19%	10.25%	7/24/2026	1,964		5,883
Mortgage (9)	P+I	1	7.25%	7.25%	7/17/2027	—		4,076
Mortgage	P+I	1	7.25%	7.25%	9/19/2027	1,404		1,411
Mortgage (9)	P+I	1	7.25%	7.25%	7/17/2027	—		5,221
Mortgage	I/O	1	14.68%	13.09%	1/17/2025	—		1,299
Mortgage	P+I	1	7.25%	7.25%	9/19/2027	1,416		1,434
Mortgage	I/O	1	7.00%	7.00%	9/30/2029	636		636
Mortgage	I/O	1	6.50%	6.50%	12/23/2029	3,284		3,284
Mortgage	I/O	1	6.50%	6.50%	12/23/2029	4,105		4,105
Mortgage (3) (4)	I/O	1	9.75%	9.75%	3/12/2026	~~1,533~~—		—1,829
Mortgage (3) (4) (10)	None (6)	10	9.75%	9.75%	10/30/2026	12,906		—
Mortgage (3) (8)	None (7)	10	9.75%	9.75%	1/30/2027	18,958		21,644
Mortgage	I/O	1	7.25%	7.25%	5/18/2027	6,050		—
Mortgage (9)	I/O	1	7.25%	7.25%	5/18/2027	—		6,050
Total						$	138,452	$	139,483
Mortgage (3)	I/O	1	9.75%	9.75%	12/5/2026	1,238		1,068
Unamortized loan origination costs and fees, net						55		74
Mortgage (3) (4) (10)	I/O	2	9.50%	9.50%	9/2/2027	2,226		—
Unamortized discount						(200)		(148)
Total						130,360		142,555
Total mortgage loans receivable, net						$	138,307	$	139,409
Unamortized loan origination costs and fees, net						92		81
Unamortized discount						(127)		(172)
Total mortgage loans receivable, net						$	130,325	$	142,464

(1) I/O: Interest Only; P+I: Principal and Interest.

(2) Includes amortization of discount, loan origination costs and fees, as applicable.

(3) The Company has the right, subject to certain terms and conditions, to acquire all or a portion of the underlying collateralized properties.

(4) Loans require monthly payments of interest only with principal payments occurring as borrower disposes of underlying properties, limited to the Company’s allocated investment by property. Any remaining principal balance will be repaid at or before the maturity date.

~~(5) The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.~~12

(6) Payments of both interest and principal are due at maturity.

(7) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from December 4, 2025 to February 22, 2026.

(8) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from October 26, 2025 to February 27, 2026.

(9) Loans were disposed during the three and nine months ended September 30, 2025. The table also excludes one loan that was entered into during 2025 and disposed of during the three and nine months ended September 30, 2025.

(10) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from March 28, 2026 to October 30, 2026.

Table of Contents

(5) The mortgage loan was scheduled to mature on March 10, 2026, however, the Company executed an amendment in April 2026 that extended the maturity date to June 1, 2026.

(6) The stated interest rate is variable up to 15.0% and is calculated based on contractual rent for existing collateralized properties subject to the loan agreement.

(7) Payments of both interest and principal are due at maturity.

(8) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from April 16, 2026 to January 30, 2027.

(9) Loan was disposed during the three months ended March 31, 2026.

(10) The collateralized properties are in process developments with varying maturity dates dependent upon initial funding. Maturity dates range from August 13, 2027 to September 2, 2027.

Note 5 – Intangible Assets and Liabilities

Intangible assets and liabilities consisted of the following (in thousands):

September 30, 2025

December 31, 2024

March 31, 2026

December 31, 2025

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

Gross Carrying Amount

Accumulated Amortization

Net Carrying Amount

Assets:

In-place leases

~~210~~243,~~340~~291

(7283,~~025~~555)

~~138~~159,~~315~~736

~~203~~228,~~104~~508

(6077,~~729~~628)

~~142~~150,~~375~~880

Above-market leases

1922,~~765~~675

(6,~~178~~974)

1315,~~587~~701

1922,~~644~~696

(56,~~500~~567)

1416,~~144~~129

Lease incentives

78,~~825~~646

(2,~~056~~451)

56,~~769~~195

98,~~529~~678

(12,~~656~~247)

76,~~873~~431

Total intangible assets

~~237~~274,~~930~~612

(8092,~~259~~980)

~~157~~181,~~671~~632

~~232~~259,~~277~~882

(6786,~~885~~442)

~~164~~173,~~392~~440

Liabilities:

Below-market leases

28,~~627~~581

(1112,~~105~~291)

1716,~~522~~290

2928,~~847~~627

(911,~~670~~717)

2016,~~177~~910

The remaining weighted average amortization period for the Company’s intangible assets and liabilities ~~as of September 30, 2025 and as of December 31, 2024~~ by category were as follows:

	Years Remaining
	Years Remaining as of
	September 30, 2025	December 31, 2024
	March 31, 2026	December 31, 2025
In-place leases	8.67	8.67
Above-market leases	11.57	11.49
Below-market leases	9.63	109.15
Lease incentives	8.87	108.19

The Company records amortization of in-place lease assets to amortization expense, and records net amortization of above-market and below-market lease intangibles as well as amortization of lease incentives to rental revenue. The following amounts in the accompanying condensed consolidated statements of operations and comprehensive income (loss) related to the amortization of intangible assets and liabilities for all property and ground leases (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

Three Months Ended March 31,

2025

2024

2025

2024

2026

2025

Amortization:

Amortization of in-place leases

56,~~658~~313

5,~~588~~556

~~16,875~~

~~15,659~~

Net adjustment to rental revenue:

Above-market lease assets

(~~371~~436)

(~~410~~379)

~~(1,122)~~

~~(1,239)~~

Below-market lease liabilities

~~618~~596

~~765~~641

~~1,887~~

~~2,167~~

Lease incentives

(~~212~~207)

(~~185~~192)

~~(655)~~

~~(565)~~

35(47)

~~170~~70

~~110~~

~~363~~

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of September 30, 2025, for the next five years and thereafter (in thousands):13

	Remainder of 2025		2026		2027		2028		2029		Thereafter		Total
In-place leases	$	5,780	$	22,286	$	20,547	$	17,825	$	15,410	$	56,467	$	138,315
Above-market lease assets	$	(372)	$	(1,464)	$	(1,413)	$	(1,382)	$	(1,233)	$	(7,723)	$	(13,587)
Below-market lease liabilities	612		2,368		2,298		2,171		1,990		8,083		17,522
Lease incentives	(194)		(776)		(720)		(690)		(652)		(2,737)		(5,769)
Net adjustment to rental revenue	$	46	$	128	$	165	$	99	$	105	$	(2,377)	$	(1,834)

Table of Contents

The following table provides the projected amortization of in-place lease assets to amortization expense and the net amortization of above-market, below-market, and lease incentive lease intangible assets and liabilities to rental revenue as of March 31, 2026, for the next five years and thereafter (in thousands):


	Remainder of 2026		2027		2028		2029		2030		Thereafter		Total
In-place leases	$	19,175	$	23,919	$	21,198	$	18,760	$	15,820	$	60,864	$	159,736

Above-market lease assets	(1,264)		(1,632)		(1,598)		(1,426)		(1,330)		(8,451)		(15,701)
Below-market lease liabilities	1,768		2,294		2,167		1,986		1,815		6,260		16,290
Lease incentives	(660)		(801)		(771)		(733)		(729)		(2,501)		(6,195)
Net adjustment to rental revenue	$	(156)	$	(139)	$	(202)	$	(173)	$	(244)	$	(4,692)	$	(5,606)

Note 6 – Debt

Debt consists of the following (in thousands):

					Amounts Outstanding as of
	Contractual Maturity Date	Fully Extended Maturity Date (1)	Interest Rate (2)	Hedged Interest Rate (3)	~~September~~March 3031, ~~2025~~2026		December 31, ~~2024~~2025
Debt:
2028 Term Loan	February 11, 2028	—	54.4362%	3.7858%	$	200,000	$	200,000
2029 Term Loan	July 3, 2026	January 3, 2029	54.3158%	4.8969%	250,000		250,000
2030 Term Loan A	January 15, 2029	January 15, 2030	54.2758%	3.5535%	175,000		175,000
2030 Term Loan B	January 15, 2029	January 15, 2030	54.3360%	54.0282%	175,000		—175,000
2031 Term Loan	March 25, 2031	—	54.3360%	4.5939%	200,000		—200,000
2032 Term Loan	September 24, 2032	—	54.6890%	4.9566%	~~100~~150,000		—100,000
Revolver	January 15, 2029	January 15, 2030	54.1848%	—	—88,000		~~239,000~~—
Mortgage Note	November 1, 2027	—	4.53%	—	87,~~084~~999		8,~~205~~042
Total debt					1,~~108~~245,~~084~~999		~~872~~1,~~205~~108,042
Unamortized discount and debt issuance costs					(76,~~514~~914)		(26,~~744~~897)
Unamortized deferred financing costs, net (4)					(34,~~958~~640)		(15,~~200~~657)
Total debt, net					$	1,~~096~~234,~~612~~445	$	~~868~~1,~~261~~095,488

(1) Date represents the fully extended maturity date available to the Company, subject to certain conditions, under each related debt instrument.

(2) Represents the stated interest rate within the respective debt agreement as of ~~September~~March 3031, ~~2025~~2026. The term loans and Revolver bear a floating interest rate (SOFR) plus the applicable margin as described further in “Note 6 – Debt”.

(3) Represents the weighted-average hedged fixed rate plus the applicable margin as of ~~September~~March 3031, ~~2025~~2026, as described further in “Note 6 – Debt” and “Note 7 – Derivative Financial Instruments.”

(4) The Company records deferred financing costs associated with the Revolver and loan commitment fees associated with the 2032 Term Loan in other assets, net in ~~its~~the condensed consolidated balance sheets. The Company reclassified the net amount of loan commitment fees associated with the 2029 Term Loan from other assets, net to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan. The Company partially reclassified the net allocated amount of loan commitment fees associated with the 2032 Term Loan from other assets, net to debt issuance costs upon the $50.0 million draw under the 2032 Term Loan.

PNC Term Loan Agreement

On September 25, 2025, the Company entered into a Term Loan Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and PNC Bank, National Association, as Administrative Agent (the “PNC Term Loan Agreement”), related to a senior unsecured term loan facility consisting of (i) a $200.0 million senior unsecured term loan (the “2031 Term Loan”) and (ii) a $250.0 million senior unsecured term loan (the “2032 Term Loan”, and together with the 2031 Term Loan, the “PNC Term Loans”). All $200.0 million of the 2031 Term Loan was funded on September 25, 2025. Of the $250.0 million capacity of the 2032 Term Loan commitments, $100.0 million in term loans were funded on September 25, 2025, $50.0 million in term loans were funded on January 2, 2026, and the remaining $~~150~~100.0 million ~~will~~is be available as a delayed draw term loan commitment until September 25, 2026. Subject to the terms of the PNC Term Loan Agreement, the PNC Term Loans may be increased to an amount of up to $600.0 million at the Company’s request.

The 2031 Term Loan matures on March 25, 2031 and is repayable at the Company’s option in whole or in part without premium or penalty. The 2032 Term Loan matures on September 24, 2032 and is repayable at the Company’s option in whole or in part, subject to a prepayment premium equal to (i) 2.0% of any amount repaid during the first year of the term, and (ii) 1.0% of any amount repaid during the second year of the term. 14

The interest rate applicable under the PNC Term Loans is determined by the Company’s Investment Grade Rating (as defined in the PNC Term Loan Agreement). Prior to the date the Company obtains an Investment Grade Rating (as defined in the PNC Term Loan Agreement), interest rates are based on the Company’s consolidated total leverage ratio and are determined by (A) in the case of the 2031 Term Loan, either (i) SOFR, plus a margin ranging from 1.15% to 1.60%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company’s consolidated total leverage ratio; and (B) in the case of the 2032 Term Loan, either (i) SOFR, plus a margin ranging from 1.50% to 2.20%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.50% to 1.20%, based on the Company’s consolidated total leverage ratio.

Table of Contents

~~After~~The ~~the~~2031 ~~date~~Term ~~the~~Loan ~~Company~~matures ~~obtains~~on anMarch ~~Investment Grade Rating~~25, ~~interest~~2031 ~~rates~~and ~~are~~is ~~based~~repayable onat the Company’s ~~Investment~~option ~~Grade~~in ~~Rating,~~whole ~~and~~or ~~are~~in ~~determined~~part bywithout ~~(A)~~premium inor ~~the~~penalty. ~~case~~The of2032 ~~the 2031~~ Term Loan, ~~either~~matures ~~(i)~~on ~~SOFR~~September 24, ~~plus~~2032 aand ~~margin~~is ~~ranging~~repayable ~~from~~at ~~0.80% to 1.60%, based on~~ the Company’s ~~Investment~~option ~~Grade~~in ~~Rating~~whole ~~and~~or ~~consolidated~~in ~~total leverage ratio~~part, orsubject ~~(ii)~~to a ~~Base~~prepayment ~~Rate,~~premium ~~plus~~equal ~~a margin ranging from 0.00%~~ to ~~0.60%, based on the Company’s Investment Grade Rating and consolidated total leverage ratio and~~ (~~B) in the case of the 2032 Term Loan, either (~~i) ~~SOFR, plus a margin ranging from 1.15% to~~ 2.200%, ~~based~~of onany ~~the~~amount ~~Company’s~~repaid ~~Investment~~during ~~Grade~~the ~~Rating~~first ~~and~~year ~~consolidated~~of ~~total~~the ~~leverage ratio~~term, orand (ii) ~~a Base Rate, plus a margin ranging from 0.15% to~~ 1.200%, ~~based~~of onany ~~the~~amount ~~Company’s~~repaid ~~Investment~~during ~~Grade~~the ~~Rating~~second ~~and~~year ~~consolidated~~of ~~total~~the ~~leverage ratio~~term.

Prior to the date the Company obtained an Investment Grade Rating (as defined in the PNC Term Loan Agreement), interest rates were based on the Company’s consolidated total leverage ratio and were determined by (A) in the case of the 2031 Term Loan, either (i) SOFR, plus a margin ranging from 1.15% to 1.60%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company’s consolidated total leverage ratio; and (B) in the case of the 2032 Term Loan, either (i) SOFR, plus a margin ranging from 1.50% to 2.20%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Term Loan Agreement), plus a margin ranging from 0.50% to 1.20%, based on the Company’s consolidated total leverage ratio.

After the date the Company obtained an Investment Grade Rating, interest rates are based on the Company’s credit rating, and are determined by (A) in the case of the 2031 Term Loan, either (i) SOFR, plus a margin ranging from 0.80% to 1.60%, based on the Company’s credit rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.60%, based on the Company’s credit rating and consolidated total leverage ratio and (B) in the case of the 2032 Term Loan, either (i) SOFR, plus a margin ranging from 1.15% to 2.20%, based on the Company’s credit rating and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.15% to 1.20%, based on the Company’s credit rating and consolidated total leverage ratio.

Additionally, the Company will incur a ticking fee based on the total undrawn amount under the 2032 Term Loan. The ticking fee of 0.20% per annum will accrue from December 25, 2025 until September 25, 2026.

The Company has fully hedged the 2031 Term Loan with an all-in fixed interest rate of 4.5939% and has partially hedged $200.0 million of the 2032 Term Loan at an all-in fixed interest rate of 4.9267%. The remaining $50.0 million of the 2032 Term Loan is currently unhedged. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in “Note 7 – Derivative Financial Instruments.”

In connection with the entry into the PNC Term Loan Agreement, the Company incurred approximately $3.7 million of debt issuance costs, which were allocated between the 2031 Term Loan and 2032 Term Loan in the amounts of $2.2 million and $1.5 million, respectively. Additionally, the Company incurred $2.1 million of loan commitment fees associated with the 2032 Term Loan, which ~~have~~were ~~been~~initially capitalized to other assets, net in the condensed consolidated balance sheets. Of the $2.1 million of loan commitment fees, $0.7 million was reclassified to debt issuance costs upon the $50.0 million draw under the 2032 Term Loan. The deferred financing costs and capitalized loan commitment fees are amortized over the term of the loans, and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

Truist Credit Agreement

On July 3, 2023, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the financial institutions party thereto, as lenders, and Truist Bank, as Administrative Agent (the “Truist Credit Agreement”), related to a $250.0 million sustainability-linked senior unsecured term loan (the “2029 Term Loan”), which may, subject to the terms of the Truist Credit Agreement, be increased to an amount of up to $400.0 million at the Company’s request. On January 15, 2025, the Truist Credit Agreement was amended to remove certain financial covenants and provide for revised, improved pricing when the Company meets certain investment grade rating and leverage targets. On September 25, 2025, the Truist Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the 2029 Term Loan.

The 2029 Term Loan contains a 12-month delayed draw feature and $150.0 million was drawn on July 3, 2023. ~~Subject~~The ~~to the terms of the Truist Credit Agreement, the~~ Company drew an additional $100.0 million under the 2029 Term Loan on March 1, 2024. The 2029 Term Loan is prepayable at the Company’s option in whole or in part without premium or penalty. The 2029 Term Loan matures on July 3, 2026, subject to two one-year extension options and one six-month extension option with a final, extended maturity date of January 3, 2029. The extension options are at the Company’s election and are subject to certain conditions.

~~The~~Prior ~~interest rate applicable~~ to the ~~2029~~date ~~Term Loan is determined by~~ the Company’s obtained an Investment Grade Rating (as defined in the Truist Credit Agreement)~~. Prior to the date the Company obtains an Investment Grade Rating~~, interest ~~shall~~accrued ~~accrue~~ at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the Truist Credit Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company ~~obtains~~obtained an Investment Grade Rating, interest ~~shall~~accrues ~~accrue~~ at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s ~~Investment~~credit ~~Grade Rating~~rating.

The 2029 Term Loan also contains sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company’s annualized based rent attributable to tenants with commitments or quantifiable targets for reduced GHG emission in accordance with the standards of the Science Based Targets initiative (“SBTi”).15

The Company has fully hedged the 2029 Term Loan at an all-in fixed interest rate of 4.89% through January 2029. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in “Note 7 – Derivative Financial Instruments.”

Table of Contents

InThe ~~connection with the entry into the~~ 2029 Term Loan, ~~the~~also ~~Company~~contains ~~incurred~~sustainability-linked ~~$1.4 million~~pricing ofcomponent ~~debt~~pursuant ~~issuance~~to ~~costs.~~which ~~Additionally,~~ the Company ~~incurred~~will ~~$0.9 million~~receive ofinterest ~~loan~~rate ~~commitment~~reductions ~~fees~~up ~~associated with the 2029 Term Loan, which were capitalized~~ to ~~other~~0.025% ~~assets,~~based ~~net~~on inits ~~the~~performance ~~condensed~~against ~~consolidated~~a ~~balance~~sustainability ~~sheets~~performance ~~and~~target ~~subsequently~~focused ~~reclassified~~on ~~to debt issuance costs upon~~ the ~~$100.0 million~~portion ~~draw~~of ~~under~~ the ~~2029~~Company’s ~~Term~~annualized ~~Loan.~~based ~~Deferred~~rent ~~financing~~attributable ~~costs~~to ~~are~~tenants ~~amortized~~with ~~over~~commitments ~~the~~or ~~term~~quantifiable oftargets ~~the~~for ~~loan~~reduced ~~and~~GHG ~~are~~emission ~~included~~ in ~~interest~~accordance ~~expense,~~with ~~net in~~ the ~~Company’s~~standards ~~condensed~~of ~~consolidated~~the ~~statements~~Science ofBased ~~operations~~Targets ~~and~~initiative ~~comprehensive loss~~(“SBTi”).

The Company has fully hedged the 2029 Term Loan at an all-in fixed interest rate of 4.69% through January 2029. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in “Note 7 – Derivative Financial Instruments.”

In connection with the entry into the 2029 Term Loan, the Company incurred $1.4 million of debt issuance costs. Additionally, the Company incurred $0.9 million of loan commitment fees associated with the 2029 Term Loan, which were capitalized to other assets, net in the condensed consolidated balance sheets and subsequently reclassified to debt issuance costs upon the $100.0 million draw under the 2029 Term Loan. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

PNC Credit Agreement

On August 11, 2022, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and PNC Bank, National Association, as Administrative Agent (the “PNC Credit Agreement”), related to sustainability-linked senior unsecured credit facility consisting of (i) a $200.0 million senior unsecured term loan (the “2028 Term Loan”) and (ii) a $400.0 million senior unsecured revolving credit facility (the “Revolver”).

On January 15, 2025, the Company amended and restated the existing PNC Credit Agreement to provide for: the existing $200.0 million 2028 Term Loan; an upsized $500.0 million Revolver (increased from $400.0 million ~~under the existing PNC Credit Agreement~~); and a new $175.0 million senior unsecured term loan (the “2030 Term Loan B”, and together with the 2028 Term Loan and the Revolver, the “PNC Credit Facility”). On September 25, 2025, the PNC Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the PNC Credit Facility. The borrowing capacity under the PNC Credit Facility may be increased in an amount of up to $1.4 billion in the aggregate, subject to certain conditions.

The 2028 Term Loan matures on February 11, 2028. The 2030 Term Loan B and the upsized Revolver initially mature on January 15, 2029 and include, at the Company’s election, a one-year option to extend the maturity to January 15, 2030, subject to certain conditions. Borrowings under the PNC Credit Facility are repayable at the Company’s option in whole or in part without premium or penalty. Borrowings under the Revolver may be repaid and reborrowed from time to time prior to the maturity date.

Prior to the date the Company ~~obtains~~obtained an Investment Grade Rating (as defined in the PNC Credit Agreement), interest rates ~~are~~were based on the Company’s consolidated total leverage ratio and ~~are~~were determined by (A) in the case of the 2028 Term Loan and the 2030 Term Loan B, either (i) SOFR, plus a margin ranging from 1.15% to 1.60%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.15% to 0.60%, based on the Company’s consolidated total leverage ratio; and (B) in the case of the Revolver either (i) SOFR, plus a margin ranging from 1.00% to 1.45%, based on the Company’s consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.00% to 0.45%, based on the Company’s consolidated total leverage ratio.

After the date the Company ~~obtains~~obtained an Investment Grade Rating, interest rates are based on the Company’s ~~Investment~~credit ~~Grade Rating~~rating, and are determined by (A) in the case of the 2028 Term Loan and the 2030 Term Loan B, either (i) SOFR, plus a margin ranging from 0.80% to 1.60%, based on the Company’s ~~Investment~~credit ~~Grade~~rating ~~Rating~~ and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.60%, based on the Company’s ~~Investment~~credit ~~Grade~~rating ~~Rating~~ and consolidated total leverage ratio and (B) in the case of the Revolver either (i) SOFR, plus a margin ranging from 0.725% to 1.40%, based on the Company’s ~~Investment~~credit ~~Grade~~rating ~~Rating~~ and consolidated total leverage ratio, or (ii) a Base Rate, plus a margin ranging from 0.00% to 0.40%, based on the Company’s ~~Investment~~credit ~~Grade~~rating ~~Rating~~ and consolidated total leverage ratio.

Additionally, the Company will incur a facility fee based on the total commitment amount of $500.0 million under the Revolver. Prior to the date the Company ~~obtains~~obtained an Investment Grade Rating, the applicable facility fee ~~will~~ranged ~~range~~ from 0.15% to 0.30% based on the Company’s consolidated total leverage ratio. After the date the Company ~~obtains~~obtained an Investment Grade Rating, the applicable facility fee ~~will~~ranges ~~range~~ from 0.125% to 0.30% based on the Company’s ~~Investment~~credit ~~Grade Rating~~rating.

The PNC Credit Facility also contains a sustainability-linked pricing component pursuant to which the Company will receive interest rate reductions up to 0.025% based on its performance against a sustainability performance target focused on the portion of the Company’s annualized base rent attributable to tenants with commitments or quantifiable targets for reduced greenhouse gas emission in accordance with the standards of the SBTi.16

The Company has fully hedged the 2028 Term Loan with an all-in fixed interest rate of 3.78%, and the 2030 Term Loan B with an all-in fixed interest rate of 5.02%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in “Note 7 – Derivative Financial Instruments.”

Table of Contents

InThe ~~connection with the entry into the~~ PNC Credit ~~Agreement,~~Facility ~~the~~also ~~Company~~contains ~~incurred~~a ~~approximately~~sustainability-linked ~~$3.8 million~~pricing ofcomponent ~~deferred~~pursuant ~~financing~~to ~~costs~~ which ~~were allocated between~~ the ~~Revolver~~Company ~~and~~will ~~2028~~receive ~~Term~~interest ~~Loan~~rate inreductions ~~the~~up ~~amounts of $2.4 million and $1.3 million, respectively. In connection with the first amendment~~ to ~~the PNC Credit Agreement, the Company incurred approximately $5~~0.~~1 million~~025% ofbased ~~deferred~~on ~~financing~~its ~~costs~~performance ~~which~~against ~~were~~a ~~allocated~~sustainability ~~between~~performance ~~the~~target ~~Revolver~~focused ~~and~~on ~~2030 Term Loan B in~~ the ~~amounts~~portion of ~~$3.7 million and $1.4 million, respectively. Additionally, $0.5 million of unamortized deferred financing costs associated with~~ the Company’s ~~previous~~annualized ~~revolving~~base ~~credit~~rent ~~facility~~attributable ~~were reclassified~~ to ~~the~~tenants ~~Revolver.~~with ~~Deferred~~commitments ~~financing~~or ~~costs~~quantifiable ~~are~~targets ~~amortized~~for ~~over~~reduced ~~the~~greenhouse ~~remaining~~gas ~~terms~~emission ~~of each respective borrowing and are included~~ in ~~interest~~accordance ~~expense,~~with ~~net in~~ the ~~Company’s~~standards ~~condensed consolidated statements~~ of ~~operations~~the ~~and comprehensive loss~~SBTi.

The Company has fully hedged the 2028 Term Loan with an all-in fixed interest rate of 3.58%, and the 2030 Term Loan B with an all-in fixed interest rate of 4.82%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are further described in “Note 7 – Derivative Financial Instruments.”

In connection with the entry into the PNC Credit Agreement, the Company incurred approximately $3.8 million of deferred financing costs, which were allocated between the Revolver and 2028 Term Loan in the amounts of $2.4 million and $1.3 million, respectively. In connection with the first amendment to the PNC Credit Agreement, the Company incurred approximately $5.1 million of deferred financing costs, which were allocated between the Revolver and 2030 Term Loan B in the amounts of $3.7 million and $1.4 million, respectively. Additionally, $0.5 million of unamortized deferred financing costs associated with the Company’s previous revolving credit facility were reclassified to the Revolver. Deferred financing costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

Wells Fargo Credit Agreement

In December 2019, the Company entered into a Credit Agreement, by and among the Operating Partnership, the Company, the several institutions party thereto, as lenders, and Wells Fargo Bank, National Association, as Administrative Agent, which was subsequently amended and restated on June 15, 2023 (as amended, the “Wells Fargo Credit Agreement”), governing a $175.0 million senior unsecured term loan that was scheduled to mature on January 15, 2026, subject to a one-year extension option at the Company’s election (subject to certain conditions) (the “2027 Term Loan”).

On January 15, 2025, the Company amended and restated the Wells Fargo Credit Agreement to extend the maturity date of the 2027 Term Loan to January 15, 2029, subject to a one-year extension option at the Company’s election (subject to certain conditions) (as amended, the “2030 Term Loan A”). On September 25, 2025, the Wells Fargo Credit Agreement was further amended to, among other things, remove the SOFR credit spread adjustment from the 2030 Term Loan A. The 2030 Term Loan A is repayable at the Company’s option in whole or in part without premium or penalty.

~~The~~Prior ~~interest rate applicable~~ to the ~~2030~~date ~~Term Loan A is determined by~~ the Company’s obtained an Investment Grade Rating (as defined in the Wells Fargo Credit Agreement)~~. Prior to the date the Company obtains an Investment Grade Rating~~, interest ~~shall~~accrued ~~accrue~~ at either (i) SOFR, plus a margin ranging from 1.15% to 1.60% or (ii) Base Rate (as defined in the Wells Fargo Credit Agreement), plus a margin ranging from 0.15% to 0.60%, in each case based on the Company’s consolidated total leverage ratio. After the date the Company ~~obtains~~obtained an Investment Grade Rating, interest ~~shall~~accrues ~~accrue~~ at either (i) SOFR, plus a margin ranging from 0.80% to 1.60% or (ii) Base Rate, plus a margin ranging from 0.00% to 0.60%, in each case based on the Company’s ~~Investment~~credit ~~Grade Rating~~rating.

The Company has fully hedged the 2030 Term Loan A with an all-in fixed interest rate of 3.5535%. Interest is payable monthly or at the end of the applicable interest period in arrears on any outstanding borrowings. The interest rate hedges are described in “Note 7 – Derivative Financial Instruments.”

In connection with the 2030 Term Loan A, the Company incurred $1.1 million of deferred financing costs. Deferred financing costs are amortized over the term of the loan and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

~~Mortgage~~Reduced ~~Note~~Margins ~~Payable~~on Debt

As of ~~September~~ December 30, 2025, ~~the~~as ~~Company~~a ~~had~~result ~~total gross mortgage indebtedness~~ of ~~$8.1 million,~~receiving ~~which~~an ~~was~~investment ~~collateralized~~grade bycredit ~~related~~rating, ~~real~~the ~~estate~~interest ~~and~~rates aon ~~tenant~~the Company’s ~~lease~~term ~~with~~loans ~~an aggregate net book value of $11.8 million. The Company incurred debt issuance costs of less than $0.1 million~~ and ~~recorded~~revolving acredit ~~debt discount of $0.6 million~~facility, ~~both~~including ~~of which are recorded as a reduction of~~ the ~~principal~~revolving ~~balance~~credit infacility ~~mortgage~~fee, ~~note~~are ~~payable,~~now ~~net~~determined inby the Company’s ~~condensed~~credit ~~consolidated~~rating ~~balance~~and ~~sheets.~~consolidated ~~The~~total ~~mortgage~~leverage ~~note matures on November 1, 2027, but may be repaid in full beginning August 2027~~ratio.

1917

Table of Contents

Mortgage Note Payable

As of March 31, 2026, the Company had total gross mortgage indebtedness of $8.0 million, which was collateralized by related real estate and a tenant’s lease with an aggregate net book value of $11.5 million. The Company incurred debt issuance costs of less than $0.1 million and recorded a debt discount of $0.6 million, both of which are recorded as a reduction of the principal balance in mortgage note payable, net in the Company’s condensed consolidated balance sheets. The mortgage note matures on November 1, 2027, but may be repaid in full beginning August 2027.

Debt Maturities

Payments on the 2028 Term Loan, 2029 Term Loan, 2030 Term Loan A, 2030 Term Loan B, 2031 Term Loan, and 2032 Term Loan are interest-only through maturity. As of ~~September~~March 3031, ~~2025~~2026, scheduled debt maturities, including balloon payments, are as follows (in thousands):

	Scheduled Principal Payment		Balloon Payment (1)		Total
Remainder of 2025	$	43	$	—	$	43
Remainder of 2026	$	134	$	250,000	$	250,134
2026	178		250,000		250,178
2027	170		7,695		7,865
2027	170		7,693		7,863
2028	—		200,000		200,000
2029	—		~~350~~438,000		~~350~~438,000
Thereafter	—		300,000		300,000
2030	—		—		—
Total	$	391	$	1,107,693	$	1,108,084
Thereafter	—		350,000		350,000
Total	$	304	$	1,245,695	$	1,245,999

(1) Does not assume the exercise of any extension options available to the Company.

Interest Expense

The following table is a summary of the components of interest expense related to the Company’s borrowings (in thousands):

Three Months Ended September 30,

Nine Months Ended September 30,

Three Months Ended March 31,

2025

2024

2025

2024

2026

2025

Revolving credit facilities (1)

~~1,758~~278

1,~~876~~461

~~5,324~~

~~4,635~~

Term loans (2)

912,~~303~~280

68,~~528~~558

~~26,854~~

~~18,728~~

Mortgage note payable

9491

9493

~~280~~

~~285~~

Non-cash:

Amortization of deferred financing costs

~~305~~350

~~186~~251

~~856~~

~~609~~

Amortization of debt discount and debt issuance costs, net

~~480~~650

~~401~~442

~~1,394~~

~~1,150~~

Amortization of deferred losses (gains) on interest rate swaps

720

(990)

2,138

(2,949)

Amortization of deferred losses on interest rate swaps

705

Capitalized interest

(2488)

(~~130~~50)

~~(112)~~

~~(709)~~

Total interest expense, net

1214,~~636~~266

711,~~965~~460

~~36,734~~

~~21,749~~

(1) Includes facility fees of approximately $0.2 3 million ~~for the three months ended September 30, 2025~~ and ~~2024, and facility fees of~~ $0.6 2 million ~~and $0.5 million~~ for the ~~nine~~three months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024~~2025, respectively.

(2) Includes the effects of interest rate hedges.

Deferred financing, discount, and debt issuance costs are amortized over the remaining terms of each respective borrowing and are included in interest expense, net in the Company’s condensed consolidated statements of operations and comprehensive income (loss).

~~During~~The ~~the~~Company ~~three~~was ~~months~~in ~~ended~~compliance ~~September~~with ~~30,~~all ~~2025 and 2024, term loans had a weighted average interest rate, exclusive~~ of ~~amortization~~its ofdebt ~~deferred~~covenants ~~financing~~as ~~costs and the effects~~ of ~~interest rate hedges~~March 31, of2026 ~~5.36%~~ and ~~6.62%,~~expects ~~respectively.~~to ~~During~~be ~~the~~in ~~nine~~compliance ~~months~~for ~~ended September 30, 2025 and 2024, term loans had a weighted average interest rate, exclusive of amortization of deferred financing costs and~~ the ~~effects~~twelve ofmonth ~~interest~~period ~~rate~~ending ~~hedges, of 5.~~December 31~~% and 6.67%~~, ~~respectively~~2026.

During the three months ended September 30, 2025 and 2024, the Company incurred interest expense on the Revolver with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 5.56% and 6.45%, respectively. During the nine months ended September 30, 2025 and 2024, the Company incurred interest expense on the Revolver with a weighted average interest rate, exclusive of amortization of deferred financing costs and facility fees, of 5.47% and 6.49%, respectively.18

The Company was in compliance with all of its debt covenants as of September 30, 2025 and expects to be in compliance for the twelve-month period ending December 31, 2025.

Table of Contents

Note 7 – Derivative Financial Instruments

The Company uses interest rate derivative contracts to manage its exposure to changes in interest rates on its variable rate debt. These derivatives are considered cash flow hedges and are recorded on a gross basis at fair value. Assessments of hedge effectiveness are performed quarterly using either a qualitative or quantitative approach. The Company recognizes the entire change in the fair value in Accumulated Other Comprehensive Income (“AOCI”), and the change is reflected as cash flow hedge changes in fair value in the supplemental disclosures of non-cash investing and financing activities in the condensed consolidated statements of cash flows.

Amounts will subsequently be reclassified to earnings when the hedged item affects earnings. The Company does not enter into derivative contracts for speculative or trading purposes and does not have derivative netting arrangements.

The Company is exposed to credit risk in the event of non-performance by its derivative counterparties. The Company evaluates counterparty credit risk through monitoring the creditworthiness of counterparties, which includes review of debt ratings and financial performance. To mitigate credit risk, the Company enters into agreements with counterparties it considers credit-worthy, such as large financial institutions with favorable credit ratings.

The following table summarizes the terms and fair values of the Company’s interest rate derivative contracts that were designated as cash flow hedges of interest rate risk ~~as of September 30, 2025 and December 31, 2024~~ (dollars in thousands):

	Number of Instruments				Aggregate Notional Value				Fair Value of Asset (Liability)(2)
Associated Debt Instrument	~~September~~March 3031, ~~2025~~2026	December 31, ~~2024~~2025	Hedge Fixed Rate(1)	Maturity Dates	~~September~~March 3031, ~~2025~~2026		December 31, ~~2024~~2025		~~September~~March 3031, ~~2025~~2026		December 31, ~~2024~~2025
2028 Term Loan	3	3	2.63%	February 11, 2028	$	200,000	$	200,000	$	3,~~126~~434	$	72,~~971~~620
2029 Term Loan	4	4	3.74%	January 3, 2029	250,000		250,000		(31,~~416~~406)		2(3,~~165~~198)
2030 Term Loan A	4	4	2.40%	January 23, 2027	175,000		175,000		21,~~471~~785		51,~~629~~806
2030 Term Loan B	7	7	3.87%	January 2, 2030	175,000		175,000		(32,~~900~~177)		~~661~~(3,467)
2031 Term Loan	8	—8	3.44%	March 1, 2031	200,000		—200,000		~~(826)~~1,062		—(185)
2032 Term Loan	8	—8	3.42%	September 1, 2032	200,000		—200,000		~~(79)~~2,292		—1,140
Total	34	1834			$	1,200,000	$	~~800~~1,200,000	$	(24,~~624)~~990	$	16(1,~~426~~284)

(1) Represents the weighted-average hedge fixed rate of the derivative contracts for each associated debt instrument and excludes the associated applicable margin as described in “Note 6 – Debt.”

(2) Derivative contracts in asset positions are included within other assets, net and derivative contracts in liability positions are included within accounts payable, accrued expenses, and other liabilities in the condensed consolidated balance sheets as of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025.

The following table presents the effect of the Company’s interest rate swaps in the condensed consolidated statements of operations and comprehensive income (loss) ~~for the three and nine months ended September 30, 2025 and 2024~~ (in thousands):

	Amount of Gain (Loss) Recognized in OCI on Derivative (Effective Portion)				Location of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	Amount of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)
Derivatives in Cash Flow Hedging Relationships	~~2025~~Three Months Ended March 31,		~~2024~~			~~2025~~Three Months Ended March 31,		~~2024~~
For the Three Months Ended September 30
	2026		2025			2026		2025
Interest Rate Products	$	~~201~~7,421	$	(158,~~724~~372)	Interest expense, net	$	~~1,605~~443	$	41,~~890~~492
For the Nine Months Ended September 30
Interest Rate Products	$	(12,251)	$	2,933	Interest expense, net	$	4,660	$	14,389

The Company did not exclude any amounts from the assessment of hedge effectiveness for the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024~~2025. During the next twelve months, the Company estimates that an additional $01.76 million will be reclassified as a decrease to interest expense.

2119

Table of Contents

Note 8 – Fair Value Measurements

GAAP establishes a hierarchy of valuation techniques based on the observability of inputs used in measuring financial instruments at fair value. GAAP establishes market-based or observable inputs as the preferred source of values, followed by valuation models using management assumptions in the absence of market inputs.

The determination of where an asset or liability falls in the hierarchy requires significant judgment and considers factors specific to the asset or liability. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety.

Financial Assets and Liabilities

Companies are required to disclose the estimated fair values of all financial instruments, even if those instruments are not carried at fair value. The fair values of financial instruments are based on estimates that reflect market conditions and perceived risks as of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025. These estimates require management’s judgment and may not be indicative of the future fair values of the assets and liabilities.

The carrying values of the Company’s cash, cash equivalents, and restricted cash (including money market accounts), other assets, and accounts payable, accrued expenses, and other liabilities approximate their fair values due to the short-term nature of these instruments. Additionally, the Company believes that the following financial instruments have carrying values that approximate their fair values as of ~~September~~March 3031, ~~2025~~2026:

•Borrowings under the Company’s Revolver (as defined in “Note 6 – Debt”) approximate fair value based on their nature, terms, and variable interest rates.

•Carrying values of the Company’s mortgage loans receivable approximate fair value based on a number of factors, including either their short-term nature, the availability of market quotes for comparable instruments, and a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

•Carrying value of the Company’s mortgage note payable approximates fair value based on a discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads.

The table below presents the carrying values and estimated fair values of certain financial assets and liabilities ~~as of September 30~~, ~~2025 and December 31, 2024,~~ aggregated by their level in the fair value hierarchy within which those measurements fall (in thousands):

					Fair Value Hierarchy Level
Description	Carrying Value		Fair Value		Level 1		Level 2		Level 3
September 30, 2025
March 31, 2026
Assets
Derivative assets	$	58,~~597~~573	$	58,~~597~~573	$	—	$	58,~~597~~573	$	—
Liabilities
Derivative liabilities	$	83,~~221~~583	$	83,~~221~~583	$	—	$	83,~~221~~583	$	—
Term loans (1)	$	1,~~092~~143,~~846~~284	$	1,~~104~~153,~~202~~027	$	—	$	—	$	1,~~104~~153,~~202~~027
December 31, 2024
December 31, 2025
Assets
Derivative assets	$	165,~~426~~566	$	165,~~426~~566	$	—	$	165,~~426~~566	$	—
Liabilities
Term loans (1)	$	622,608	$	626,629	$	—	$	—	$	626,629
Derivative liabilities	$	6,850	$	6,850	$	—	$	6,850	$	—
Term loans (1)	$	1,093,331	$	1,103,089	$	—	$	—	$	1,103,089

(1) Recorded at carrying value in the condensed consolidated balance sheets which represents amortized cost, net of unamortized debt issuance and discount costs.

The estimated fair values of the Company’s term loans (each as defined in “Note 6 – Debt”) are derived based primarily on unobservable market inputs such as interest rates and discounted cash flow analysis using estimates of the amount and timing of future cash flows, market rates, and credit spreads (Level 3 inputs).

2220

Table of Contents

The Company’s derivative assets and liabilities are measured at fair value on a recurring basis. The estimated fair values are determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves.

To comply with the provisions of ASC 820, ~~Fair Value Measurement,~~ the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings, thresholds, mutual puts, and guarantees.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by itself and its counterparties. However, as of ~~September~~March 3031, ~~2025~~2026, the Company has assessed the significance of the impact of the credit valuation adjustments on the overall valuation of its derivative positions and has determined that the credit valuation adjustments are not significant to the overall valuation of its derivatives. As a result, the Company has determined that its derivative valuations in their entirety are classified in Level 2 of the fair value hierarchy.

Nonfinancial Assets and Liabilities

Certain nonfinancial assets and liabilities are measured at fair value on a non-recurring basis and are subject to fair value adjustments only under certain circumstances, such as when an impairment write-down occurs. Depending on impairment triggering events, impairments are typically recorded for properties sold, in the process of being sold, vacant, in bankruptcy, or experiencing difficulties with collection of rent.

The following table summarizes the provisions for impairment on real estate investments during the periods indicated below (dollars in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
Carrying value prior to impairment	$	3716,~~870~~763	$	4824,~~237~~048	$	~~80,992~~	$	~~101,196~~
Less: total provisions for impairment	(41,~~134~~488)		(93,~~838~~616)		~~(12,173)~~		~~(17,336)~~
Carrying value after impairment	$	3315,~~736~~275	$	3820,~~399~~432	$	~~68,819~~	$	~~83,860~~
Number of properties: (1)
Classified as held for sale	56		1211		11		17
Disposed within the period	71		31		21		14
Classified as held for investment	12		31		2		9

(1) Includes the number of properties that were either (i) impaired during the respective period and remained as held for sale as of period-end, (ii) impaired and disposed during the respective period, or (iii) impaired during the respective period and remained as held for investment at period-end.

The valuation of impaired assets is determined using data such as operating income, estimated capitalization rates or multiples, leasing prospects, local market information, analysis of recent comparable sales transactions, discount rates, and purchase offers from third parties, all of which represent Level 3 inputs. The Company may consider a single valuation technique or multiple valuation techniques, as appropriate, when estimating the fair value of such real estate. Estimating future cash flows is inherently subjective, and actual results may differ materially from these estimates. During the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026, the Company accounted for held for investment assets at fair value using apurchase ~~cash~~offers ~~flow model (Level 3 inputs) with capitalization rates ranging~~ from ~~6.2%~~third ~~to 7.5%~~parties, which the Company believes is reasonable ~~based on current market rates~~.

2321

Table of Contents

Note 9 – Supplemental Detail for Certain Components of the Condensed Consolidated Balance Sheets

Other assets, net consists of the following (in thousands):

	September 30, 2025		December 31, 2024
	March 31, 2026		December 31, 2025
Accounts receivable, net	$	814,~~763~~324	$	9,~~809~~679
Deferred rent receivable	1518,~~331~~905		1116,~~790~~588
Prepaid assets	47,~~286~~176		2,~~143~~975
Earnest money deposits	~~993~~1,195		~~517~~6,790
Fair value of interest rate swaps	58,~~597~~573		165,~~426~~566
Deferred offering costs	2,~~400~~724		12,~~641~~171
Deferred financing costs, net	64,~~032~~640		15,~~200~~657
Right-of-use asset	32,~~187~~984		3,~~484~~086
Leasehold improvements and other corporate assets, net	1,~~240~~107		1,~~425~~183
Interest receivable	3,~~737~~905		3,~~034~~958
Other assets, net	5,~~392~~233		65,~~758~~423
	$	5670,~~958~~766	$	5863,~~227~~076

Accounts payable, accrued expenses, and other liabilities ~~consist~~consists of the following (in thousands):

	September 30, 2025		December 31, 2024
	March 31, 2026		December 31, 2025
Accrued expenses	$	89,~~585~~979	$	4,~~961~~249
Accrued bonus	~~2,118~~647		13,~~271~~068
Prepaid rent	46,~~757~~774		56,~~655~~526
Operating lease liability	4,~~281~~027		4,~~646~~155
Accrued interest	34,~~928~~480		34,~~476~~642
Deferred rent	45,~~985~~511		45,~~738~~233
Accounts payable	~~554~~500		31,~~053~~218
Fair value of interest rate swaps	83,~~221~~583		—6,850
Other liabilities	4,528		1,864
Tenant improvement allowances	4,060		3,975
	$	41,957	$	29,664
Other liabilities	2,442		2,643
	$	42,003	$	42,559

Note 10 – Shareholders’ Equity

ATM Programs

On October 25, 2023, the Company entered into a $300.0 million at-the-market equity program (the “2023 ATM Program”) through which, from time to time, it may sell shares of its common stock in registered transactions.

During 2024, the Company entered into forward sale agreements with respect to an aggregate 1,743,100 shares of its common stock under the 2023 ATM Program at a weighted-average price of $17.67 per share. ~~As of September 30, 2025, 1,743,100 shares remain unsettled under the forward sale agreements.~~ The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than December 31, 2026.

On August 12, 2024, the Company entered into a $300.0 million at-the-market equity program (the “2024 ATM Program”) through which, from time to time, it may sell shares of its common stock in registered transactions. Effective August 12, 2024, in connection with the establishment of the new at-the-market offering program, the 2023 ATM Program was terminated. As a result of the termination, the Company will not offer or sell any additional shares of common stock under the 2023 ATM Program. As context requires, the 2024 ATM Program, and the 2023 ATM Program are referred to herein as the “ATM Programs.”

2422

Table of Contents

During ~~2024~~the three months ended March 31, 2026, the Company entered into forward sale agreements with respect to an aggregate ~~152~~3,~~547~~956,031 shares of its common stock under the 2024 ATM Program at a weighted-average price of $1718.1381 per share. ~~As of September 30, 2025, 152,547 shares remain unsettled under the forward sale agreements.~~ The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than ~~December~~the ~~31,~~stated ~~2025~~maturity dates ranging from January 2027 to March 2027.

During 2025, the Company entered into forward sale agreements with respect to an aggregate 39,~~342~~068,~~894~~486 shares of its common stock under the 2024 ATM Program at a weighted-average price of $1617.9575 per share. ~~As of September 30, 2025, 2,237,595 shares remain unsettled under the forward sale agreements.~~ The Company may physically settle the forward sale agreements (by the delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than the stated maturity dates ofranging ~~April~~from ~~30, 2026, June 11, 2026,~~ September 8, 2026, ~~and~~to ~~September~~November 9, 2026.

The following table presents information about the ATM Programs (in thousands):

	Date Established	Date Terminated	Maximum Sales Authorization		Gross Settlements through September 30, 2025 (1)		Gross Proceeds Available as of September 30, 2025 (2)
					As of March 31, 2026
Program Name	Date Established	Date Terminated	Maximum Sales Authorization		Value of Gross Proceeds Settled(1)		Value of Gross Proceeds of Unsettled Forward Equity		Value of Gross Proceeds Available for Issuance(2)
2023 ATM Program (3)	October 2023	August 2024	$	300,000	$	77,323	$	30,806
2023 ATM Program(3)	October 2023	August 2024	$	300,000	$	77,323	$	30,806	$	—
2024 ATM Program (4)	August 2024	—	$	300,000	$	28,694	$	271,306
2024 ATM Program(4)	August 2024	—	$	300,000	$	52,446	$	197,623	$	49,931

(1) Represents gross proceeds received from shares of common stock issued by the Company under the ATM Programs, including settlements of forward sale agreements.

(2) Represents gross proceeds available for future issuances of shares of common stock under the ATM Programs~~, inclusive of unsettled shares under forward sale agreements~~.

(3) As of ~~September~~March 3031, ~~2025~~2026, 1,743,100 shares remain unsettled under the forward sale agreements at a weighted-average available net settlement price of $17.3315.

(4) As of ~~September~~March 3031, ~~2025~~2026, 210,~~390~~726,~~142~~818 shares remain unsettled under the forward sale agreements at a weighted-average available net settlement price of $1718.0612.

~~The~~February ~~following~~2026 ~~table~~Follow-On details information related to activity under the ATM Programs for the three and nine months ended September 30, 2025 and 2024 (in thousands, except share and per share data). There was no activity during the three months ended September 30, 2025. Offering

	Three Months Ended September 30,				Nine Months Ended September 30,
	2025		2024 (1)		2025 (2)		2024 (3)
Shares of common stock issued	—		1,983,711		1,757,815		5,983,711
Weighted average price per share	$	—	$	16.50	$	16.32	$	16.50
Gross proceeds	$	—	$	32,731	$	28,694	$	98,731
Sales commissions and offering costs	$	—	$	394	$	342	$	1,070
Net proceeds (4)	$	—	$	32,337	$	28,352	$	97,661

In February 2026, the Company completed a registered public offering of 12,627,000 shares of its common stock at a public offering price of $19.00 per share, including the full exercise of the underwriters’ option to purchase additional shares. In connection with the offering, the Company entered into forward sale agreements for 12,627,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers.

~~(1)~~As ~~Includes~~of 1March 31,~~983~~ 2026,~~711~~ 12,627,000 shares remain unsettled under the February 2026 forward sale agreements. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) ~~that~~and ~~were~~receive ~~physically~~proceeds ~~settled~~from atthe asale ~~weighted-average~~of ~~price~~those ofshares ~~$16.50~~upon ~~per~~one ~~share~~or ~~under~~more forward ~~sale~~settlement ~~agreements~~dates, which shall occur no later than February 12, 2027.

(2) Includes 1,105,299 shares of common stock that were physically settled at a weighted-average price of $16.37 per share under forward sale agreements.

(3) Includes 5,983,711 shares of common stock that were physically settled at a weighted-average price of $16.50 per share under forward sale agreements.

(4) The net proceeds were contributed to the Operating Partnership in exchange for an equivalent number of Class A OP Units.

July 2025 Follow-On Offering

In July 2025, the Company completed a registered public offering of 12,420,000 shares of its common stock at a public offering price of $17.70 per share, including the full exercise of the underwriter’s option to purchase additional shares. In connection with the offering, the Company entered into forward sale agreements for 12,420,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than July 28, 2026. As of September 30, 2025, 12,420,000 shares remain unsettled under the July 2025 forward sale agreements.

Table of Contents

January 2024 Follow-On Offering

In January 2024, the Company completed a registered public offering of 11,040,000 shares of its common stock at a public offering price of $18.00 per share. In connection with the offering, the Company entered into forward sale agreements for 11,040,000 shares of its common stock. The Company did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. On September 26, 2024, the Company partially physically settled 2,200,000 shares of common stock at a price of $17.22 per share in accordance with the forward sale agreements. The Company received net proceeds from the settlement of $37.8 million, net of underwriting discounts and offering costs of $1.8 million. The Company contributed the net proceeds to the Operating Partnership in exchange for 2,200,000 Class A OP Units.

~~The~~On ~~Company~~February ~~expects~~6, to2026, the Company physically ~~settle~~settled ~~the~~4,000,000 ~~forward~~shares ~~sale~~of ~~agreements~~common ~~(by~~stock ~~delivery~~at ofa ~~shares~~weighted-average price of ~~common~~$16.98 ~~stock)~~per ~~and~~share ~~receive~~in ~~proceeds~~accordance ~~from~~with the forward sale ofagreements. ~~those~~The ~~shares~~Company ~~upon~~received ~~one~~net orproceeds ~~more~~from ~~forward~~the settlement ~~dates~~of $67.8 million, ~~which~~net ~~shall~~of ~~occur~~underwriting nodiscounts ~~later~~and ~~than~~offering ~~December~~costs ~~31,~~of ~~2026~~$4.2 million. AsThe ofCompany ~~September 30,~~contributed ~~2025,~~the ~~8,840,000~~net ~~shares~~proceeds ~~remain~~to ~~unsettled~~the ~~under~~Operating ~~the~~Partnership ~~January~~in ~~2024~~exchange ~~forward~~for ~~sale~~4,000,000 ~~agreements~~OP Units (as defined below).

As of March 31, 2026, 4,840,000 shares remain unsettled under the January 2024 forward sale agreements. The Company expects to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than December 31, 2026.

Table of Contents

The following table presents information about the Company’s January 2024, July 2025, and February 2026 follow-on offerings (in thousands, except share data):


			As of March 31, 2026
Follow-On Offering	Shares Sold	Shares Settled	Shares Unsettled	Value of Gross Proceeds of Unsettled Forward Equity
January 2024	11,040,000	6,200,000	4,840,000	$	87,120
July 2025	12,420,000	8,155,053	4,264,947	$	75,490
February 2026	12,627,000	—	12,627,000	$	239,913

Surrendered Shares on Vested Stock Unit Awards

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024~~2025, portions of restricted stock unit awards (“RSUs”) granted to certain of the Company’s officers, directors, and employees vested. The vesting of these awards, granted pursuant to the NETSTREIT Corp. Amended and Restated 2019 Omnibus Incentive Plan (the “Omnibus Incentive Plan”), resulted in federal and state income tax liabilities for the recipients. During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 and ~~2024~~2025, as permitted by the terms of the Omnibus Incentive Plan and the award grants, certain executive officers and employees elected to surrender approximately 5083 thousand and 7740 thousand RSUs valued at approximately $01.7 million and $10.36 million, respectively, solely to pay the associated statutory withholding tax. The surrendered RSUs are included in the row entitled “repurchase of common stock for tax withholding obligations” in the condensed consolidated statements of cash flows and condensed consolidated statements of changes in equity.

Dividends

During the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Nine Months Ended September 30, 2025
Three Months Ended March 31, 2026
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 21, 2025	$	0.210	March 14, 2025	$	17,157	March 31, 2025
February 5, 2026	$	0.220	March 16, 2026	$	21,396	March 31, 2026
April 25, 2025	0.210		June 2, 2025	17,159		June 16, 2025
July 21, 2025	0.215		September 2, 2025	17,947		September 15, 2025
	$	0.635		$	52,263

During the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025, the Company declared and paid the following common stock dividends (in thousands, except per share data):

Nine Months Ended September 30, 2024
Three Months Ended March 31, 2025
Declaration Date	Dividend Per Share		Record Date	Total Amount		Payment Date
February 13, 2024	$	0.205	March 15, 2024	$	15,031	March 28, 2024
February 21, 2025	$	0.210	March 14, 2025	$	17,157	March 31, 2025
April 23, 2024	0.205		June 3, 2024	15,042		June 14, 2024
July 23, 2024	0.210		September 3, 2024	16,251		September 13, 2024
	$	0.620		$	46,324

The holders of OP Units are entitled to receive an equal distribution for each OP Unit held as of each record date. Accordingly, during both the nine months ended September 30, 2025 and 2024, the Operating Partnership paid distributions of $0.3 million to holders of OP Units.

Table of Contents

Noncontrolling Interests

~~Noncontrolling~~NETSTREIT ~~interests~~GP, ~~represent~~LLC, ~~noncontrolling~~a ~~holders~~wholly ofowned OPsubsidiary ~~Units~~of in the ~~Operating Partnership. OP Units are convertible into common stock as the OP Units may be redeemed for cash or~~Company, atis the ~~Company’s~~sole ~~election,~~general ~~exchanged~~partner ~~for shares~~ of the ~~Company’s~~Operating ~~common~~Partnership ~~stock~~and onholds a ~~one-for-one basis~~1. ~~As of September 30, 2025 and December 31, 2024, noncontrolling interests represented~~ 0.5% ofgeneral OPpartner ~~Units.~~interest ~~During~~in the ~~three~~Operating ~~months~~Partnership. ~~ended~~The ~~September~~Company ~~30,~~contributes ~~2025~~net ~~and~~proceeds ~~2024,~~from OPissuing ~~Unit holders redeemed 5,694 and 12,102 OP Units, respectively, into~~ shares of common stock onto athe ~~one-for-one~~Operating ~~basis.~~Partnership ~~During~~in ~~the~~exchange ~~nine~~for ~~months~~common ~~ended~~units ~~September~~of ~~30,~~limited ~~2025~~partnership ~~and~~interest ~~2024,~~in OPthe ~~Unit~~Operating ~~holders~~Partnership ~~redeemed~~(the ~~5,694~~“OP ~~and~~Units”) ~~54,342~~equal OPto ~~Units,~~the ~~respectively,~~number ~~into~~of shares of common stock ~~on a one-for-one basis~~issued.

As of March 31, 2026, the Company held 97,253,523 OP Units and external parties (the “Noncontrolling OP Unit Holders”) held 402,178 OP Units, representing 99.6% and 0.4%, respectively, of OP Units. As of December 31, 2025, the Company held 97,070,533 OP Units and Noncontrolling OP Unit Holders held 412,143 OP Units, representing 99.6% and 0.4%, respectively, of OP Units. The OP Units held by Noncontrolling OP Unit Holders are presented as noncontrolling interests in the Company’s condensed consolidated financial statements.

The holders of OP Units are entitled to receive an equal distribution for each OP Unit held as of each record date. During the three months ended March 31, 2026 and 2025, the Operating Partnership paid distributions of $0.1 million to Noncontrolling OP Unit Holders.

Table of Contents

OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis. During the three months ended March 31, 2026, Noncontrolling OP Unit Holders redeemed 9,965 OP Units for shares of common stock on a one-for-one basis. There were no OP Unit redemptions during the three months ended March 31, 2025.

Note 11 – Stock-Based Compensation

Under the Omnibus Incentive Plan, 4,294,976 shares of common stock are reserved for issuance and, as of March 31, 2026, 3,134,013 shares of common stock were available for future issuance under the Omnibus Incentive Plan. The Omnibus Incentive Plan provides for the grant of stock options, stock appreciation rights, restricted shares, RSUs, ~~long-term~~LTIP ~~incentive~~Units ~~plan~~(as ~~units~~defined below), dividend equivalent rights, and other share-based, share-related, or cash-based awards, including performance-based awards, to employees, directors, and consultants, with each grant evidenced by an award agreement providing the terms of the award. The Omnibus Incentive Plan is administered by the Compensation Committee of the Board of Directors.

As of ~~September~~March 3031, ~~2025~~2026, the only stock-based compensation granted by the Company were RSUs and LTIP Units. The total amount of stock-based compensation costs recognized in general and administrative expense in the accompanying condensed consolidated statements of operations and comprehensive income (loss) was $1.57 million and $1.4 million for the three months ended ~~September 30~~March 31, ~~2025~~2026 and ~~2024, respectively. Stock-based compensation expense was $4.4 million and $4.7 million for the nine months ended September 30,~~ 2025 ~~and 2024~~, respectively. All awards of unvested ~~restricted~~RSUs ~~stock~~and ~~units~~LTIP Units are expected to fully vest ~~over~~within the next ~~one to~~ five years.

The following table summarizes RSU and LTIP Unit activity for the period indicated below:


	Restricted Stock Units						LTIP Units
	Service-Based			Performance			Service-Based			Performance
	Units	Weighted Average Grant Date Fair Value per Unit		Units	Weighted Average Grant Date Fair Value per Unit		Units	Weighted Average Grant Date Fair Value per Unit		Units(1)	Weighted Average Grant Date Fair Value per Unit
Unvested grants outstanding as of December 31, 2025	452,646	$	15.85	392,130	$	16.45	—	$	—	—	$	—
Granted during the period	112,480	19.85		—	—		125,559	19.85		121,691	20.74
Forfeited during the period	—	—		(17,609)	20.86		—	—		—	—
Vested during the period	(202,695)	16.07		(53,173)	21.81		—	—		—	—
Unvested grants outstanding as of March 31, 2026	362,431	$	16.97	321,348	$	15.32	125,559	$	19.85	121,691	$	20.74

(1) The number of Performance LTIP Units disclosed is based on the target level of awards being achieved, with the ultimate number earned subject to the achievement of specified performance metrics over a three-year performance period, ranging from 0% to 200% of target. The actual number of Performance LTIP Units issued on the grant date assumes maximum performance is achieved.

Service-Based RSUs

Pursuant to the Omnibus Incentive Plan, the Company has made service-based RSU grants to certain employees and non-employee directors. The vesting terms of these grants are specific to the individual grant and vest in equal annual installments ~~over~~within the next one to five years.

~~The~~For ~~following~~the ~~table~~three ~~summarizes~~months ended March 31, 2026 and 2025, the Company recognized $0.9 million and $0.8 million, respectively, in stock-based compensation expense associated with service-based ~~RSU~~RSUs. ~~activity~~As ~~for~~of ~~the~~March 31, ~~period~~2026 ~~ended~~and ~~September~~December 3031, 2025:, the remaining unamortized stock-based compensation expense totaled $5.0 million and $3.9 million, respectively, and as of March 31, 2026, these awards are expected to be recognized over a remaining weighted average period of 2.1 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2024	326,987	$	18.25
Granted during the period	279,345	14.55
Forfeited during the period	(2,963)	17.01
Vested during the period	(163,112)	18.70
Unvested RSU grants outstanding as of September 30, 2025	440,257	$	15.74

The grant date fair value of unvested service-based RSUs is the per share price of the Company’s stock on the date of grant.

For the three months ended September 30, 2025 and 2024, the Company recognized $0.9 million and $0.8 million, respectively, in stock-based compensation expense associated with service-based RSUs. For the nine months ended September 30, 2025 and 2024, the Company recognized $2.6 million and $2.6 million, respectively, in stock-based compensation expense associated with service-based RSUs. As of September 30, 2025 and December 31, 2024, the remaining unamortized stock-based compensation expense totaled $4.5 million and $3.3 million, respectively, and as of September 30, 2025, these awards are expected to be recognized over a remaining weighted average period of 2.0 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.25

The grant date fair value of service-based unvested RSUs is calculated as the per share price determined in the initial public offering for awards granted in 2020, and as the per share price of the Company’s stock on the date of grant for those granted in years subsequent to 2020.

Table of Contents

Performance-Based RSUs (total shareholder return)

Pursuant to the Omnibus Incentive Plan, the Company has made performance-based RSU grants to certain employees. These grants are subject to the participant’s continued service over a three -year period with 40% of the award based on the Company’s total shareholder return (“TSR”) as compared to the TSR of identified peer companies and 60% of the award based on total absolute TSR over the cumulative three -year period. The performance period of these grants runs through ~~February 28, 2026,~~ December 31, 2026, and December 31, 2027. Grant date fair value of the performance-based share awards was calculated using the Monte Carlo simulation model, which incorporated stock price volatility of the Company and each of the Company’s peers and other variables over the performance period. Significant inputs for the current period calculation were expected volatility of the Company of 24.4% and expected volatility of the Company’s peers, ranging from 19.5% to 98.2%, with an average volatility of 29.9% and a risk-free interest rate of 4.00%. The fair value per share on the grant date specific to the target TSR relative to the Company’s peers was $15.86 and the target absolute TSR was $14.28 for a weighted average grant date fair value of $14.91 per share. Stock-based compensation expense associated with unvested performance-based share awards is recognized on a straight-line basis over the minimum required service period of three years.

~~The~~For ~~following~~the ~~table~~three ~~summarizes~~months ended March 31, 2026 and 2025, the Company recognized $0.5 million in stock-based compensation expense associated with performance-based ~~RSU~~RSUs. ~~activity~~As ~~for~~of ~~the~~March 31, ~~period~~2026 ~~ended~~and ~~September~~December 3031, 2025:, the remaining unamortized stock-based compensation expense totaled $2.3 million and $2.8 million, respectively, and as of March 31, 2026, these awards are expected to be recognized over a remaining weighted average period of 1.5 years.

	Shares	Weighted Average Grant Date Fair Value per Share
Unvested RSU grants outstanding as of December 31, 2024	290,442	$	18.75
Granted during the period	170,213	14.91
Forfeited during the period	(68,525)	22.38
Unvested RSU grants outstanding as of September 30, 2025	392,130	$	16.45

LTIP Units

~~For~~On February 11, 2026, the ~~three~~Company ~~months~~entered ~~ended~~into ~~September~~the ~~30,~~Second ~~2025~~Amended and ~~2024,~~Restated Agreement of Limited Partnership of the ~~Company~~Operating ~~recognized~~Partnership ~~$0.6~~to, ~~million~~among other things, designate and ~~$0.5~~set ~~million~~forth the terms of a new class of units of limited partnership interest in the Operating Partnership (the “LTIP Units”), ~~respectively~~including Basic LTIP Units, inwhich ~~stock~~have service-based ~~compensation~~vesting ~~expense~~conditions ~~associated~~(“Basic ~~with~~LTIP Units”), and Performance LTIP Units, which have performance-based ~~RSUs~~vesting conditions (“Performance LTIP Units”). ~~For~~Each ~~both~~LTIP ~~the~~Unit ~~nine~~awarded ~~months~~is ~~ended~~deemed ~~September~~equivalent ~~30,~~to ~~2025~~an ~~and~~award ~~2024,~~of one share of stock under the ~~Company~~Omnibus ~~recognized~~Incentive ~~$1.6~~Plan, ~~million~~reducing inthe ~~stock-based~~availability ~~compensation~~for ~~expense~~other ~~associated~~equity ~~with~~awards ~~performance~~on a one-~~based~~for-one ~~RSUs~~basis. AsLTIP Units are automatically converted into OP Units upon satisfaction of ~~September 30,~~the ~~2025~~applicable ~~and~~vesting ~~December 31~~conditions, ~~2024,~~which are determined at the ~~remaining~~time ~~unamortized~~of ~~stock-based~~issuance. ~~compensation~~Following ~~expense~~the ~~totaled~~second ~~$3.3~~anniversary ~~million~~of ~~and~~the ~~$2.4~~grant ~~million~~date of the applicable LTIP Unit, ~~respectively~~each OP Unit issued upon conversion of an LTIP Unit is redeemable for cash equal to the then-current market value of one share of the Company’s common stock or, ~~and~~at asthe election of ~~September 30~~the Company, ~~2025~~one share of the Company’s common stock. From their applicable grant dates, ~~these~~unvested ~~awards~~Basic LTIP Units are ~~expected~~entitled to bereceive ~~recognized~~the ~~over~~same adistributions ~~remaining~~as ~~weighted~~OP ~~average~~Units, ~~period~~and unvested Performance LTIP Units are entitled to receive 10% of ~~1.9~~distributions ~~years~~made on OP Units and catch-up distributions are made upon vesting.

Basic LTIP Units

Pursuant to the Omnibus Incentive Plan, the Company has granted Basic LTIP Units to certain employees. The awards vest in equal annual installments over three years on each anniversary of the grant date, subject to continued service to the Company and certain exceptions.

For the three months ended March 31, 2026, the Company recognized $0.1 million in stock-based compensation expense associated with Basic LTIP Units. As of March 31, 2026, the remaining unamortized stock-based compensation expense totaled $2.4 million, and as of March 31, 2026, these awards are expected to be recognized over a remaining weighted average period of 2.9 years. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award.

The grant date fair value of Basic LTIP Units is calculated as the per share price of the Company’s common stock on the date of grant.

Performance LTIP Units

Pursuant to the Omnibus Incentive Plan, the Company has granted Performance LTIP Units to the Company’s executives and senior management team. These grants are subject to the participant’s continued service over a three-year period with 40% of the award based on the Company’s growth rate of Adjusted FFO (“AFFO”) per diluted share over a three-year performance period, and 60% of the award based on the Company’s TSR as compared to the TSR of identified peer companies over the cumulative three-year period. The payout schedule can produce vesting percentages ranging from 0% to 200% of target. The actual number of Performance LTIP Units issued on the grant date assumes maximum performance is achieved. The performance period of these grants runs through December 31, 2028.

Table of Contents

The grant date fair value of the AFFO component is the per share price of the Company’s stock on the date of grant. The grant date fair value of the TSR component was calculated using the Monte Carlo simulation model, which incorporated stock price volatility of the Company and each of the Company’s peers and other variables over the performance period. Significant inputs for the current period calculation were expected volatility of the Company of 22.4% and expected volatility of the Company’s peers, ranging from 17.6% to 38.8%, with an average volatility of 22.3%, and a risk-free interest rate of 3.5%. The fair value per share on the grant date specific to the target TSR relative to the Company’s peers was $21.34.

For the three months ended March 31, 2026, the Company recognized $0.1 million in stock-based compensation expense associated with Performance LTIP Units. As of March 31, 2026, the remaining unamortized stock-based compensation expense totaled $2.4 million, and as of March 31, 2026, these awards are expected to be recognized over a remaining weighted average period of 2.8 years. Stock-based compensation expense associated with unvested Performance LTIP Units is recognized on a straight-line basis over the minimum required service period of three years.

Alignment of Interest Program

~~During~~Under ~~March 2021,~~ the ~~Company adopted the~~ Alignment of Interest Program (the “Program”), ~~which~~the Company allows employees to elect to receive a portion of their annual bonus in RSUs in the first quarter of the following year, that vest from one to four years based on the terms of the grant agreement. Stock-based compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award, which begins in the period the bonus relates to. The Program is deemed to be a liability-classified award (accounted for as an equity-classified award as the service date precedes the grant date and the award would otherwise be classified as equity on grant date), which will be fair-valued and accrued over the applicable service period. The total estimated fair value of the elections made for ~~2025~~2026 under the Program was approximately $1.1 0 million as of ~~September~~March 3031, ~~2025~~2026. The award will be remeasured to fair value each reporting period until the unvested RSUs are granted. For the three ~~and nine~~ months ended ~~September 30~~March 31, 2026 and 2025, the Company recognized ~~approximately~~less than $0.1 million ~~and $0.2 million, respectively,~~ of stock-based compensation expense associated with these awards. Previous awards under the Program that have been granted are included within service-based RSUs above.

Note 12 – Earnings Per Share

Net income ~~(loss)~~ per common share has been computed pursuant to the guidance in the ASC Topic 260, Earnings per Share. Basic earnings per share is computed by dividing net income ~~(loss)~~ attributable to common stockholders by the weighted-average number of common shares outstanding for the period. The guidance requires the classification of the Company’s unvested LTIP Units, which contain rights to receive non-forfeitable dividends or dividend equivalents, as participating securities requiring the two-class method of computing earnings per share. Diluted earnings per share is similarly calculated; ~~except~~however, ~~that~~ the denominator is increased ~~by using the treasury stock method~~ to ~~determine~~reflect the potential dilutive effect of the Company’s outstanding unvested RSUs, LTIP Units, and unsettled shares under open forward equity contracts, ~~and~~determined using the ~~if-converted~~treasury stock method, toas ~~determine~~well ~~the~~as ~~potential~~OP ~~dilutive~~Units, ~~effect~~determined ofusing the OPif-converted ~~Units~~method. The Company has noncontrolling interests in the form of OP Units which are convertible into common stock and represent potentially dilutive securities, as the OP Units may be redeemed for cash or, at the Company’s election, exchanged for shares of the Company’s common stock on a one-for-one basis.

2827

Table of Contents

The following table is a reconciliation of the numerator and denominator used in the computation of basic and diluted net income ~~(loss)~~ per common share for the ~~three~~periods ~~and~~indicated ~~nine~~below ~~months~~(in ~~ended~~thousands, ~~September~~except ~~30,~~share ~~2025~~data and ~~2024.~~per share data):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
(In thousands, except share and per share data)	2025		2024		2025		2024
	2026		2025
Numerator:
Net income (loss)	$	621	$	(5,322)	$	5,610	$	(6,576)
Net income	$	5,711	$	1,700
Net (income) loss attributable to noncontrolling interest	(3)		27		(29)		35
Less: net income attributable to noncontrolling interest	(24)		(9)
Net income (loss) attributable to common shares, basic	618		(5,295)		5,581		(6,541)
Less: net income allocated to unvested LTIP Units	(29)		—
Net income (loss) attributable to noncontrolling interest	3		(27)		29		(35)
Net income attributable to common shares, basic	5,658		1,691
Net income (loss) attributable to common shares, diluted	$	621	$	(5,322)	$	5,610	$	(6,576)
Net income attributable to noncontrolling interest	24		9
Denominator:
Net income attributable to common shares, diluted	$	5,682	$	1,700
Weighted average common shares outstanding, basic	83,472,089		77,610,680		82,344,168		74,822,286
Denominator:
Effect of dilutive shares for diluted net income per common share:
Weighted average common shares outstanding, basic	95,543,920		81,644,492
OP Units	421,954		—		423,944		—
Effect of dilutive shares for diluted net income per common share:
Unvested RSUs	420,132		—		218,847		—
OP Units	407,714		424,956
Unsettled shares under open forward equity contracts	1,327,773		—		442,591		—
Unvested RSUs and LTIP Units	524,946		63,076
Weighted average common shares outstanding, diluted	85,641,948		77,610,680		83,429,550		74,822,286
Unsettled shares under open forward equity contracts	2,631,062		—
Net income (loss) available to common stockholders per common share, basic	$	0.01	$	(0.07)	$	0.07	$	(0.09)
Weighted average common shares outstanding, diluted	99,107,642		82,132,524
Net income (loss) available to common stockholders per common share, diluted	$	0.01	$	(0.07)	$	0.07	$	(0.09)
Net income available to common stockholders per common share, basic	$	0.06	$	0.02
Net income available to common stockholders per common share, diluted	$	0.06	$	0.02

~~For~~The ~~the~~ three months ended ~~September~~March 3031, ~~2024,~~2026 ~~diluted~~exclude ~~net loss per common share does not assume~~ the ~~conversion~~impact of ~~433~~125,~~942~~605 OPunvested ~~Units,~~RSUs ~~115,703~~and ~~unvested~~LTIP ~~RSUs,~~Units orand 10,~~219~~199 unsettled shares under open forward equity contracts, as ~~such~~the ~~conversion~~effect would behave been antidilutive.

~~For~~The ~~the~~three ~~nine~~ months ended ~~September~~March 3031, ~~2024,~~2025 ~~diluted~~exclude ~~net loss per common share does not assume~~ the ~~conversion~~impact of ~~450~~417,~~952~~052 ~~OP Units, 117,761~~ unvested RSUs, orand ~~311~~1,~~475~~886,795 unsettled shares under open forward equity contracts, as ~~such~~the ~~conversion~~effect would behave been antidilutive.

As of ~~September~~March 3031, ~~2025~~2026 and December 31, ~~2024~~2025, there were ~~419~~402,~~262~~178 and ~~424~~412,~~956~~143 of OP Units outstanding, respectively.

Note 13 – Commitments and Contingencies

Litigation and Regulatory Matters

In the ordinary course of business, the Company may, from time to time, be subject to litigation, claims, and regulatory matters. There are none currently outstanding that the Company believes could have, individually or in the aggregate, a material adverse effect on its business, financial condition or results of operations, liquidity, or cash flows.

Environmental Matters

The Company is subject to environmental regulations related to the ownership of real estate. The cost of complying with the environmental regulations was not material to the Company’s results of operations for any of the periods presented. The Company is not aware of any environmental condition on any of its properties that is likely to have a material adverse effect on the condensed consolidated financial statements when the fair value of such liability can be reasonably estimated and is required to be recognized.

2928

Table of Contents

Commitments

In the normal course of business, the Company enters into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage loans receivable. These commitments are generally subject to the Company’s customary due diligence process and, accordingly, a number of specific conditions must be met before the Company is obligated to purchase or extend funding. As of ~~September~~March 3031, ~~2025~~2026, the Company had commitments to fund property developments, extend funds under mortgage loans receivable, and fund tenant improvement ~~allowance~~allowances ~~commitments~~ totaling ~~approximately~~$22.3 million, $6.34 million, and $8.3 million, ~~commitments~~respectively. Commitments to fund property developments ~~totaling~~are ~~$6.3~~expected ~~million,~~to ~~and~~occur ~~commitments~~over tothe ~~extend~~next ~~funds~~nine ~~under~~months, commitments to fund mortgage loans receivable ofare ~~$11.4~~expected ~~million~~to occur over the next 18 months, ~~all~~and ofcommitments ~~which~~to fund tenant improvement allowances are expected to occur byover the ~~end~~next oftwo ~~2026~~years.

In August 2021, the Company entered into a lease agreement onrelated ato ~~new~~its corporate office space, which is classified as an operating lease. The Company began operating out of the ~~new~~ office in February 2022. The lease has a remaining noncancellable term of 6.83 years that expires on July 31, 2032 and is renewable at the Company’s option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

As of ~~September~~March 3031, ~~2025~~2026, the Company did not have any other material commitments for re-leasing costs, recurring capital expenditures, non-recurring building improvements, or similar types of costs.

Note 14 – Subsequent Events

The Company has evaluated all events that occurred subsequent to ~~September~~March 3031, ~~2025~~2026 through the date on which these condensed consolidated financial statements were issued to determine whether any of these events required disclosure in the financial statements.

2032 Term Loan Draw

Subject to the terms of the PNC Term Loan Agreement, the Company drew an additional $50.0 million under the 2032 Term Loan on April 1, 2026, bringing the total outstanding principal amount to $200.0 million. The Company has $50.0 million remaining under the PNC Term Loan Agreement delayed draw term loan commitment.

Common Stock Dividend

On ~~October~~April 2416, ~~2025~~2026, the Company’s Board of Directors declared a cash dividend of $0.~~215~~22 per share for the ~~fourth~~second quarter of ~~2025~~2026. The dividend will be paid on ~~December~~June 15, ~~2025~~2026 to stockholders of record on ~~December~~June 1, ~~2025~~2026.

Revolver Activity

In April 2026, the Company repaid $57.0 million on the Revolver.

Forward Equity Sales

In ~~October~~April ~~2025~~2026, the Company entered into forward sale agreements with respect to an aggregate 1307,~~556,592~~984 shares of its common stock under the 2024 ATM Program at a weighted-average price of $1819.2654 per share. The Company may physically settle the forward sale agreements (by ~~the~~ delivery of shares of common stock) and receive proceeds from the sale of those shares on one or more forward settlement dates, which shall occur no later than ~~October~~April ~~1, 2026~~2027.

~~ATM Settlements~~29

In October 2025, the Company issued 82,500 shares of common stock under the 2024 ATM Program at a price of $18.10 per share for net proceeds of approximately $1.5 million.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements concerning our business and growth strategies, investment, financing and leasing activities and trends in our business, including trends in the market for single-tenant, retail commercial real estate. Words such as “expects,” “anticipates,” “intends,” “plans,” “likely,” “will,” “believes,” “seeks,” “estimates,” and variations of such words and similar expressions are intended to identify such forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from the results of operations or plans expressed or implied by such forward-looking statements. Although we believe that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore such statements included in this Quarterly Report on Form 10-Q may not prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that the results or conditions described in such statements or our objectives and plans will be achieved. For a further discussion of these and other factors that could impact future results, performance or transactions, see the information under the heading “Risk Factors” Part I, Item 1A. in our Annual Report on Form 10-K for the year ended December 31, ~~2024~~2025, filed with the Securities and Exchange Commission (the “SEC”) on February 2410, ~~2025~~2026, and other reports filed with the Securities and Exchange Commission from time to time.

Forward-looking statements and such risks, uncertainties and other factors speak only as of the date of this Quarterly Report on Form 10-Q. New risks and uncertainties may arise over time and it is not possible for us to predict those events or how they may affect us. We expressly disclaim any obligation or undertaking to update or revise any forward-looking statement contained herein, to reflect any change in our expectations with regard thereto, or any other change in events, conditions or circumstances on which any such statement is based, except to the extent otherwise required by law.

Business Overview

We are an internally managed real estate company that acquires, owns, and manages a diversified portfolio of single-tenant commercial retail properties, subject to long-term net leases with high-credit-quality tenants across the United States. We also invest in property developments and mortgage loans secured by real estate. As of ~~September~~March 3031, ~~2025~~2026, we owned or had investments in ~~723~~808 properties diversified by tenant, industry, and geography, comprising ~~114~~138 different tenants across 28 retail sectors in 4546 states. This includes ~~two~~four property developments where rent has not yet commenced. We focus on tenants in industries where we believe a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including ~~home improvement~~grocers, ~~auto~~convenience ~~parts~~stores, ~~drug~~discount stores ~~and pharmacies~~, ~~general~~home ~~retail~~improvement, ~~grocers,~~quick-service ~~convenience stores~~restaurants, ~~discount~~general ~~stores~~retail, and ~~quick-service~~auto ~~restaurants~~parts, all of which we refer to as defensive retail industries. As of ~~September~~March 3031, ~~2025~~2026, our investments generated ABR1 of $~~183~~214.2 million. Approximately 4742% of our ABR is from investment grade2 credit rated tenants and an additional 1516% of our ABR is derived from tenants with an investment grade profile3. Our portfolio was 99.9% occupied (excluding four properties under development) and, excluding mortgage loans receivable, had a weighted average remaining lease term (“WALT”) of 910.9 2 years.

1February ~~Annualized~~2026 ~~base~~Follow-On ~~rent (“ABR”) is annualized base rent for all leases that commenced and annualized cash interest for all executed mortgage loans as of September 30, 2025.~~Offering

2In WeFebruary ~~define~~2026, ~~“investment~~we ~~grade”~~completed ~~tenants~~a asregistered ~~tenants~~public offering of 12,627,000 orshares ~~tenants~~of ~~that~~our ~~are~~common ~~subsidiaries~~stock ofat a ~~parent~~public ~~entity~~offering price of $19.00 per share, ~~with~~including athe ~~credit~~full ~~rating~~exercise of ~~BBB-~~the ~~(S&P/Fitch)~~underwriters’ option to purchase additional shares. In connection with the offering, ~~Baa3~~we ~~(Moody’s)~~entered into forward sale agreements for 12,627,000 orshares ~~NAIC2~~of ~~(National~~our ~~Association~~common stock. We did not initially receive any proceeds from the sale of ~~Insurance~~shares ~~Commissioners)~~of orcommon ~~higher~~stock by the forward purchasers.

3As Weof ~~define~~March 31, ~~“investment~~2026, ~~grade~~12,627,000 ~~profile”~~shares ~~tenants~~remain asunsettled ~~tenants~~under ~~with~~the ~~metrics~~February of2026 ~~more~~forward ~~than~~sale $1agreements.0 ~~billion~~We inexpect ~~annual~~to ~~sales~~physically ~~and~~settle athe ~~debt~~forward tosale ~~adjusted~~agreements ~~EBITDA~~(by ~~ratio~~delivery of ~~less~~shares ~~than~~of ~~2.0x~~common ~~but~~stock) doand ~~not~~receive ~~carry~~proceeds afrom ~~published~~the ~~rating~~sale ~~from~~of ~~S&P,~~those ~~Moody’s,~~shares upon one or ~~NAIC~~more forward settlement dates, which shall occur no later than February 12, 2027.

(1) Annualized base rent (“ABR”) is annualized base rent for all leases that commenced and annualized cash interest for all executed mortgage loans as of March 31, 2026.

(2) We define “investment grade” tenants as tenants, or tenants that are subsidiaries of a parent entity, with a credit rating of BBB- (S&P/Fitch), Baa3 (Moody’s), or NAIC2 (National Association of Insurance Commissioners) or higher.

(3) We define “investment grade profile” tenants as tenants that have investment grade credit metrics (more than $1.0 billion in annual sales and a debt to adjusted EBITDA ratio of less than 2.0x), but do not carry a published rating from S&P, Fitch, Moody’s, or NAIC.

Table of Contents

~~July~~Settlement ~~2025~~of Forward Shares Under the January 2024 Follow-On Offering

In ~~July~~January ~~2025~~2024, we completed a registered public offering of 1211,~~420~~040,000 shares of ~~our~~ common stock at a public offering price of $1718.7000 per share~~, including the full exercise of the underwriter’s option to purchase additional shares~~. In connection with the offering, we entered into forward sale agreements for 1211,~~420~~040,000 shares of our common stock. We did not initially receive any proceeds from the sale of shares of common stock by the forward purchasers. We expect to physically settle the forward sale agreements (by delivery of shares of common stock) and receive proceeds from the sale of those shares upon one or more forward settlement dates, which shall occur no later than July 28, 2026. As of September 30, 2025, 12,420,000 shares remain unsettled under the July 2025 forward sale agreements.

~~September~~On ~~2025~~February ~~Debt~~6, ~~Transactions~~2026, we physically settled 4,000,000 shares of common stock at a weighted-average price of $16.98 per share in accordance with the forward sale agreements. We received net proceeds from the settlement of $67.8 million, net of underwriting discounts and offering costs of $4.2 million.

OnAs ~~September 25, 2025, we entered into a Term Loan Agreement (the “PNC Term Loan Agreement”) which provides for: a $200.0 million senior unsecured term loan (the “2031 Term Loan”), all~~ of ~~which was funded on the closing date, and a $250.0~~March ~~million senior unsecured term loan (the “2032 Term Loan”)~~31, ~~of which $100.0 million was funded on the closing date and the remaining $150.0 million will be available as a delayed draw term loan commitment until September 25,~~ 2026~~. The 2031 Term Loan matures on March 25~~, ~~2031 and the 2032 Term Loan matures on September 24~~4,840,000 ~~2032.~~shares Weremain ~~have~~unsettled ~~fully~~under ~~hedged~~ the ~~2031~~January ~~Term~~2024 ~~Loan~~forward atsale ~~an all-in fixed interest rate of 4~~agreements.~~59%~~ ~~through March 2031.~~ We ~~have~~expect ~~partially~~to ~~hedged~~physically ~~$200.0 million~~settle of the ~~2032~~forward ~~Term~~sale ~~Loan~~agreements at(by andelivery ~~all-in fixed interest rate~~ of ~~4.92%~~shares ~~through September 2032, with the remaining $50.0 million~~ of ~~the~~common ~~2032 Term Loan currently unhedged. Further, we amended our existing credit agreements agented by PNC Bank, National Association (the “PNC Credit Agreement”~~stock), ~~Wells~~and ~~Fargo~~receive ~~Bank,~~proceeds ~~National~~from ~~Association (~~the ~~“Wells~~sale ~~Fargo~~of ~~Credit~~those ~~Agreement”)~~shares ~~and~~upon ~~Truist~~one ~~Bank~~or ~~(the~~more ~~“Truist~~forward ~~Credit~~settlement ~~Agreement”)~~dates, ~~implementing~~which ~~certain~~shall ~~conforming~~occur ~~changes~~no ~~including,~~later ~~without~~than ~~limitation~~December 31, ~~removing the SOFR credit spread adjustments in those agreements~~2026.

ATM Program

During ~~2025~~the three months ended March 31, 2026, we entered into forward sale agreements with respect to an aggregate 3,~~342~~956,~~894~~031 shares of common stock under ~~our~~the existing ~~ATM program at a weighted-average price of~~ $16300.950 ~~per~~million ~~share. As of September 30, 2025, 2,237,595 shares remain unsettled under~~ at-the-market ~~forward~~equity ~~sale~~program ~~agreements.~~established Wein ~~may~~August ~~physically~~2024 ~~settle the forward sale agreements~~ (by the ~~delivery~~“2024 ofATM ~~shares of common stock~~Program”) ~~and~~at ~~receive~~a ~~proceeds~~weighted-average ~~from~~price ~~the sale~~ of ~~those~~$18.81 ~~shares~~per ~~on one or more forward settlement dates, which shall occur no later than the stated maturity dates of April 30, 2026, June 11, 2026, September 8, 2026, and September 9, 2026~~share.

~~The~~As ~~following~~of ~~table~~March 31, ~~details~~2026, ~~information~~12,469,918 ~~related~~shares toremain ~~activity~~unsettled under forward sale agreements associated with our existing $300.0 million at-the-market ~~ATM~~equity program ~~for~~(the “2023 ATM Program”) and the ~~nine~~2024 ~~months~~ATM ~~ended~~Program. ~~September~~We ~~30,~~may ~~2025~~physically settle the forward sale agreements (inby ~~thousands,~~delivery ~~except~~of ~~share~~shares of common stock) and ~~per~~receive ~~share~~proceeds ~~data).~~from ~~There~~the ~~was~~sale of those shares on one or more forward settlement dates, which shall occur no ~~activity~~later ~~during~~than the ~~three~~stated ~~months~~maturity ~~ended~~dates ranging from September 302026 to March 2027. As of March 31, ~~2025~~2026, the remaining availability under the 2024 ATM Program was $49.9 million.

	Nine Months Ended September 30, 2025
Shares of common stock issued (1)	1,757,815
Weighted average price per share	$	16.32
Gross proceeds	$	28,694
Sales commissions and offering costs	$	342
Net proceeds	$	28,352

2032 Term Loan Draw

Subject to the terms of the term loan agreement agented by PNC Bank, National Association (1the “PNC Term Loan Agreement”), ~~Includes~~we 1drew an additional $50.0 million under the $250.0 million senior unsecured term loan (the “2032 Term Loan”) on January 2,~~105~~ 2026,~~299~~ ~~shares~~bringing ofthe ~~common~~total ~~stock~~outstanding ~~that~~principal ~~were~~amount ~~physically~~to ~~settled~~$150.0 million. atThe a$150.0 million ~~weighted~~outstanding under the 2032 Term Loan is hedged with an all-~~average~~in ~~price~~fixed interest rate of ~~$16~~4.3766%. ~~per~~We ~~share~~have $100.0 million remaining under ~~forward~~the ~~sale~~PNC ~~agreements.~~Term Loan Agreement delayed draw term loan commitment.

Results of Operations

Overall

We continued to grow our assets held for investment during the ~~nine~~three months ended ~~September 30~~March 31, ~~2025~~2026 through the acquisition of properties, property developments, and investment in mortgage loans receivable, with an underwritten weighted-average ~~capitalization~~cash ~~rate~~yield of approximately 7.65%. This growth was financed through the ~~PNC Term Loan Agreement and receipt of proceeds of~~ $~~200~~50.0 million ~~and~~draw ~~$100.0 million~~ under the ~~2031 Term Loan and~~ 2032 Term Loan, ~~respectively, the amendment of our PNC Credit Agreement and receipt of proceeds under our $175.0 million senior unsecured term loan (the “2030 Term Loan B”),~~ settlement of shares of common stock through our ~~forward~~January ~~sale agreements in an amount of $17.9 million, the issuance of common stock under the~~ 2024 ~~ATM~~Follow-On ~~Program~~Offering in an amount of $1067.5 8 million, the usage of cash balances as a result of borrowings on our senior unsecured revolving credit facility (the “Revolver”), the usage of restricted cash balances as a result of tax-free exchanges under Section 1031 of the Internal Revenue Code of 1986, and cash flows from operations during the ~~nine~~three months ended ~~September 30~~March 31, ~~2025~~2026.

Table of Contents

Acquisitions

During the three months ended ~~September 30~~March 31, ~~2025~~2026, we acquired 4656 properties for a total purchase price of $~~194~~234.30 million, inclusive of $2.3.0 million of capitalized acquisition costs. The acquisitions were all accounted for as asset acquisitions. These properties are located in 2017 states with a WALT of approximately 1314.41 years.

During the nine months ended September 30, 2025, we acquired 87 properties for a total purchase price of $368.3 million, inclusive of $4.2 million of capitalized acquisition costs. The acquisitions were all accounted for as asset acquisitions. These properties are located in 28 states with a WALT of approximately 13.1 years.

Development

As of ~~September~~March 3031, ~~2025~~2026, we had ~~two~~four property developments under construction., ~~During~~which ~~the~~are ~~three~~expected ~~and~~to ~~nine~~be ~~months~~substantially ~~ended~~completed ~~September~~with ~~30,~~rent ~~2025,~~commencing weat ~~invested~~various ~~$0.1~~points ~~million~~throughout 2026 and ~~$2.2~~early ~~million, respectively, in property developments~~2027. During the ~~nine~~three months ended ~~September 30~~March 31, ~~2025~~2026, we ~~completed~~invested ~~development on two projects and reclassified approximately~~ $6.5.4 million ~~from~~in property ~~under development to land~~developments, ~~buildings~~including ~~and improvements, and other assets (leasing commissions) in~~ the ~~accompanying~~land ~~condensed~~acquisition ~~consolidated balance sheets. Rent commenced for both~~ of ~~the~~one ~~completed~~new ~~developments~~development inwith ~~the~~an ~~second~~initial ~~quarter~~purchase price of ~~2025~~$2.3 ~~The remaining two developments are expected to be substantially completed with rent commencing at various points throughout 2026~~million. The purchase price, including acquisition costs, and subsequent development are included in property under development in the accompanying condensed consolidated balance sheets as of ~~September~~March 3031, ~~2025~~2026.

Table of Contents

Dispositions

During the three months ended ~~September 30~~March 31, ~~2025~~2026, we sold 24five properties for a total sales price, net of disposal costs, of $3610.04 million, recognizing a net gain of $10.1 million ~~on the sales~~. ~~During the nine months ended September 30, 2025, we sold 60 properties for a total sales price, net of disposal costs, of $130.2 million, recognizing a net gain of $6.7 million on the sales.~~

Investment in Mortgage Loans Receivable

During the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026, we invested an additional $95.61 million ~~and $35.3 million, respectively,~~ in fully collateralized mortgage loans receivable with stated interest rates ranging from 79.0050% to 109.2575%. In addition, during the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026, we collected $1211.52 million ~~and $24.7 million, respectively,~~ in principal on our mortgage loans receivable. ~~Additionally,~~We we sold ~~three~~one mortgage ~~loans~~loan receivable at a discount in an effort to manage tenant exposure, recognizing non-credit related provisions for impairment of $10.46 million for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2025~~2026. See discussion of our mortgage loans receivable portfolio included in “Note 4 – Real Estate Investments” of our condensed consolidated financial statements, included in “Item 1 – Financial Statements (unaudited)”.

33Three Months Ended March 31, 2026 Compared with Three Months Ended March 31, 2025

Table of Contents

Economic and Financial Environment

Changes in global or national market and economic conditions, such as global economic and financial market volatility and global geopolitical conflict, have caused, and may continue to cause, among other things, tightening in the credit markets, lower levels of liquidity, fluctuating interest rates and inflation, increases in the rate of default and bankruptcy, and lower consumer and business spending, which could materially and adversely affect us. For example, the current and continuing macro-economic conditions, including variable inflation and changing interest rates, may increase the costs associated with acquiring new properties and decrease the availability of financing on terms that we find attractive, which could reduce our ability to acquire properties at our historical rate with attractive terms. Additionally, other macroeconomic pressures in the U.S. and the global economy, including new and proposed tariffs on imports into the United States and current and potential countermeasures by foreign governments and recession fears, may impact our tenants as consumers reduce discretionary spending. A decline in consumer spending has had and may continue to have an adverse effect on tenants which, in turn, could impact our performance if tenants terminate leases or otherwise fail to pay rents. Other potential consequences of changes in economic and financial conditions include: changes in the performance of our tenants, which may result in lower rent and lower recoverable expenses, and tenant defaults under the lease; current or potential tenants may delay or postpone entering into long-term leases with us; increased costs of acquiring new properties on attractive terms; inability to borrow on terms and conditions that we find to be acceptable, which could reduce our ability to pursue acquisition opportunities or increase future interest expense; and the recognition of impairment charges on or reduced values of our properties, which may adversely affect our results of operations or limit our ability to dispose of assets at attractive prices and may reduce the availability of buyer financing. We are also limited in our ability to reduce costs to offset the results of a prolonged or severe economic downturn given certain fixed costs and commitments associated with our operations. We continually monitor the commercial real estate and credit markets carefully and, if required, will make decisions to adjust our business strategy accordingly.

Three Months Ended September 30, 2025 Compared with Three Months Ended September 30, 2024

The following table sets forth our operating results for the periods indicated (in thousands):

	Three Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2025		2024
	2026		2025
Revenues
Rental revenue (including reimbursable)	$	4554,~~026~~027	$	3842,~~172~~590
Interest income on loans receivable	3,~~282~~035		3,~~272~~075
Total revenues	48,308		41,444
Other revenue	—		245
Total revenues	57,062		45,910
Operating expenses
Property	45,~~302~~404		4,~~494~~803
General and administrative	5,~~128~~755		45,~~287~~169
Depreciation and amortization	2124,~~389~~463		20,~~438~~923
Provisions for impairment	52,~~493~~062		93,~~838~~616
Transaction costs	19		26
Transaction costs, net	(60)		47
Total operating expenses	3637,~~331~~624		3934,~~083~~558
Other (expense) income
Interest expense, net	(1214,~~636~~266)		(711,~~965~~460)
Gain (loss) on sales of real estate, net	1,122		(132)
Gain on sales of real estate, net	119		2,075
Other income, net	170		416
Loss on debt extinguishment	—		(46)
Total other expense, net	(11,344)		(7,681)
Other income (expense), net	434		(205)
Net income (loss) before income taxes	633		(5,320)
Total other expense, net	(13,713)		(9,636)
Income tax expense	(12)		(2)
Net income before income taxes	5,725		1,716
Net income (loss)	$	621	$	(5,322)
Income tax expense	(14)		(16)
Net income	$	5,711	$	1,700

Revenue. Revenue for the three months ended ~~September~~March 3031, ~~2025~~2026 increased by $611.92 million to $4857.31 million from $4145.4 9 million for the three months ended ~~September~~March 3031, ~~2024~~2025, which is primarily attributed to an increase in the number of our operating leases. The increase includes additional cash rental receipts of $59.85 million, an increase of $1.2 million in straight-line rental revenue, combined net increases of property expense reimbursements of $0.75 million, and ana ~~increase~~net decrease of $0.43 million in ~~straight-line~~reserves ~~rental~~for uncollectible amounts, offset by a decrease in other revenue of $0.2 million related to a lease termination fee during the three months ended March 31, 2025 and other combined net decreases of $0.1 million.

Total operating expenses. Total expenses increased by $3.0 million to $37.6 million for the three months ended March 31, 2026 as compared to $34.6 million for the three months ended March 31, 2025. The increase is primarily attributed to an increase in the number of operating properties, with the most significant increase being depreciation and amortization expense. Total operating expenses include the following:

Table of Contents

~~Total~~•Property ~~operating~~ expenses. ~~Total~~Property ~~operating~~ expenses ~~decreased~~increased by $20.8 6 million to $365.3 4 million for the three months ended ~~September~~March 3031, ~~2025~~2026 asfrom ~~compared to~~ $394.1 8 million for the three months ended ~~September~~March 3031, ~~2024~~2025. The ~~decrease~~increase is primarily attributed to aan ~~decrease~~increase in ~~provisions~~the ~~for~~number ~~impairment~~of operating properties, including combined net increases of reimbursable property expenses of $0.5 million, of which $0.5 million and $0.1 million were related to reimbursable property taxes and reimbursable insurance costs, respectively, partially offset by ~~increases~~a indecrease ~~depreciation~~of ~~and~~$0.2 ~~amortization~~million ~~expense~~of reimbursable common area maintenance costs, and ~~payroll~~combined net increases of non-~~related~~reimbursable property expenses of $0.2 ~~Total~~million ~~operating~~primarily ~~expenses~~related ~~include~~to ~~the~~common ~~following:~~area maintenance costs and property insurance.

•~~Property~~General and administrative expenses. ~~Property~~General and administrative expenses ~~decreased~~increased by $0.26 million to $45.3 8 million for the three months ended ~~September~~March 3031, ~~2025~~2026 from $4.5 .2 million for the three months ended ~~September~~March 3031, ~~2024~~2025. The ~~decrease~~increase is primarily ~~attributed~~related to ~~combined~~an ~~net~~increase ~~decreases~~of $0.4 million of ~~reimbursable~~payroll ~~property~~expense ~~expenses~~and an increase of $0.23 million, ofin ~~which~~stock ~~$0.4~~based ~~million~~compensation ~~were~~expense, ~~related~~offset toby ~~reimbursable~~other ~~common~~combined ~~area~~net ~~maintenance~~decreases ~~and~~of $0.1 million. ~~were~~While ~~related~~our general and administrative expenses will continue to ~~reimbursable~~rise ~~insurance~~in some measure as our portfolio grows, ~~partially~~we ~~offset~~expect bythat ansuch ~~increase~~expenses ofas ~~$0.3~~a ~~million~~percentage of ~~reimbursable~~our ~~property~~portfolio ~~taxes~~ABR and total assets will decrease over time due to efficiencies and economies of scale.

•~~General~~Depreciation and ~~administrative expenses~~amortization. ~~General~~Depreciation and ~~administrative~~amortization ~~expenses~~expense increased by $03.86 million to $524.15 million for the three months ended ~~September~~March 3031, ~~2025~~2026 from $420.39 million for the three months ended ~~September~~March 3031, ~~2024~~2025. The ~~increases~~increase ~~within~~in ~~general~~depreciation and ~~administrative~~amortization ~~expense~~is ~~were~~proportionate ~~primarily related~~ to anthe increase ofin ~~$0.6~~the ~~million~~size of ~~bonus~~the ~~expense~~portfolio ~~and~~over anthe ~~increase~~comparable ofperiod ~~$0.2~~with ~~million~~associated ofincreases ~~payroll~~primarily ~~expense. While our general and administrative expenses will continue to rise~~ in ~~some~~building ~~measure~~depreciation asexpense ~~our~~of ~~portfolio~~$2.1 ~~grows~~million, wein-place ~~expect~~lease ~~that~~amortization ~~such~~expense ~~expenses, as a percentage~~ of ~~our~~$0.8 ~~portfolio~~million, ~~ABR~~ and ~~total~~building ~~assets,~~improvements ~~will~~depreciation ~~decrease~~expense ~~over time due to operating efficiencies and economies~~ of ~~scale~~$0.7 million.

•~~Depreciation~~Provisions ~~and~~for ~~amortization~~impairment. ~~Depreciation~~ ~~and~~For ~~amortization~~the ~~expense~~three ~~increased~~months byended ~~$1.0~~March 31, ~~million~~2026, towe recorded provisions for impairment of $212.41 million ~~for~~on nine properties and one mortgage loan receivable, the ~~three~~majority ~~months~~of ~~ended~~which ~~September 30~~were either previously classified as held-for-sale, ~~2025~~newly ~~from~~classified ~~$20.4 million~~as held-for-sale, ~~the~~or disposed during three months ended ~~September~~March 3031, ~~2024~~2026. ~~The~~Of ~~increase~~those inproperties ~~depreciation~~impaired, ~~and~~two ~~amortization~~properties iswere ~~proportionate~~held tofor ~~the~~investment ~~increase~~as ~~in the size~~ of ~~the~~March 31, ~~portfolio~~2026. ~~over~~For the ~~comparable~~three ~~period~~months ~~with~~ended ~~associated~~March 31, ~~increases~~2025, ~~primarily~~we inrecorded ~~building~~provisions ~~depreciation~~for ~~expense~~impairment of $03.6 million, ~~building~~on ~~improvements~~13 ~~depreciation~~properties, ~~expense~~the majority of $0which were newly classified as held-for-sale during the three months ended March 31, 2025.3 ~~million~~Of those properties impaired, ~~and~~one ~~in-place~~property ~~lease~~was ~~amortization~~held ~~expense~~for investment as of $0March 31, 2025.1 ~~million~~These disposals relate to management’s continuous assessment of our portfolio in an effort to improve returns and manage risk exposure.

~~•Provisions~~Interest expense. Interest expense increased by $2.8 million to $14.3 million for ~~impairment~~the three months ended March 31, 2026 from $11. ~~For~~5 million for the three months ended ~~September~~March 3031, 2025,. weThe ~~recorded~~increase ~~provisions~~is ~~for~~primarily ~~impairment~~attributed to an increase of $52.5 2 million of interest incurred on 13our ~~properties~~$200.0 ~~and~~million ~~three~~senior ~~mortgage~~unsecured ~~loans~~term ~~receivable,~~loan (the ~~majority~~“2031 Term Loan”), an increase of ~~which~~$1.7 ~~were~~million ~~either~~of ~~previously~~interest ~~classified~~incurred ason ~~held-for-sale~~our 2032 Term Loan, ~~newly~~and ~~classified~~in asincrease ~~held-for-sale~~of $0.3 million in loan fee amortization, ormost ~~disposed~~of ~~during~~which is related to the ~~three~~2031 ~~months~~Term ~~ended~~Loan ~~September 30,~~and ~~2025.~~2032 ~~One~~Term ofLoan. ~~the~~The ~~properties~~increase was ~~held~~partially ~~for~~offset ~~investment~~by as$1.2 million of ~~September 30~~reduced interest incurred on our Revolver, ~~2025.~~primarily ~~For~~due ~~the~~to ~~three~~a ~~months~~decrease ~~ended~~in ~~September 30,~~average ~~2024,~~borrowings weoutstanding ~~recorded~~during ~~provisions~~the ~~for~~respective ~~impairment~~periods, ofand $90.8 3 million of reduced interest incurred on 18our ~~properties,~~$200.0 million senior unsecured term loan (the ~~majority~~“2028 ofTerm ~~which~~Loan”), ~~were~~our ~~classified~~$250.0 asmillion ~~held-for-sale~~senior orunsecured ~~disposed~~term ~~during~~loan (the ~~three~~“2029 ~~months~~Term ~~ended September 30~~Loan”), ~~2024~~our $175.0 ~~Three~~million ofsenior ~~the~~unsecured ~~properties~~term ~~were~~loan ~~held~~(the ~~for~~“2030 ~~investment~~Term asLoan ~~of September 30~~A”), ~~2024~~and our $175.0 ~~Property~~million ~~disposals~~senior ~~relate~~unsecured toterm ~~management’s~~loan ~~continuous~~(the ~~assessment~~“2030 ofTerm Loan B”), primarily related to the ~~Company’s~~interest ~~portfolio~~rate inreduction anas ~~effort~~a toresult ~~improve~~of ~~returns~~receiving ~~and~~a ~~manage~~credit ~~risk~~rating ~~exposure~~at the end of 2025.

~~Interest~~Gain ~~expense~~on sales of real estate, net. ~~Interest~~Net ~~expense~~gain ~~increased~~on sales of real estate decreased by $42.60 million to $120.6 1 million for the three months ended ~~September~~March 3031, ~~2025~~2026 from $82.0 1 million for the three months ended ~~September~~March 3031, ~~2024~~2025. ~~The~~For ~~increase~~the isthree ~~primarily~~months ~~attributable~~ended toMarch 31, an2026, ~~increase~~five ofproperties ~~$2.7~~were ~~million~~sold offor ~~interest~~a ~~related~~sales toprice, ~~our~~net ~~term~~of ~~loans~~disposal costs, of ~~which~~ $210.34 million. ~~was~~For ~~related~~the tothree ~~our~~months ~~new~~ended ~~2030~~March 31, ~~Term~~2025, ~~Loan~~16 B,properties anwere ~~increase~~sold offor ~~$1.7~~a ~~million~~sales inprice, ~~amortization~~net of ~~deferred~~disposal ~~losses on interest rate swaps~~costs, ~~and an increase~~ of $038.26 million ~~in amortization of loan fees associated with the January 2025 debt transactions~~.

~~Gain~~Other income (~~loss~~expense) ~~on sales of real estate~~, net. ~~Net~~ ~~gain~~Other income (~~loss~~expense), onnet ~~sales of real estate~~ increased by $10.26 million to a $10.14 million ~~gain~~of other income, net for the three months ended ~~September~~March 3031, ~~2025~~2026 from a $0.12 million ~~loss~~of other expense, net for the three months ended ~~September~~March 3031, ~~2024~~2025. ~~For~~The ~~the~~net ~~three~~increase ~~months~~to ~~ended~~income ~~September~~is ~~30,~~primarily ~~2025,~~related 24to ~~properties~~a ~~were~~$0.3 ~~sold~~million ~~for~~increase ain ~~sales~~interest ~~price,~~income ~~net~~on ofbank ~~disposal~~accounts ~~costs,~~and ofa $~~36.~~0.4 million. ~~For~~decrease ~~the~~in ~~three~~third-party ~~months~~debt ~~ended~~issuance ~~September~~costs ~~30,~~that ~~2024,~~were ~~eight~~expensed ~~properties~~during ~~were~~the ~~sold~~three ~~for~~months aended ~~sales~~March ~~price~~31, ~~net~~2025 ofas ~~disposal~~a ~~costs,~~result of ~~$23.0~~the ~~million~~January 2025 debt transaction.

~~Other~~Net income~~, net~~. ~~Other~~Net income, ~~net~~increased ~~decreased~~ by $04.20 million to $05.27 million for the three months ended ~~September~~March 3031, ~~2025~~2026 from $01.47 million for the three months ended ~~September~~March 3031, ~~2024~~2025. ~~The~~Net ~~decrease~~income isincreased primarily ~~related~~due to aadditional ~~$0.2~~rental ~~million~~revenues, ~~reduction~~primarily due to the growth in ~~insurance~~the ~~recoveries~~size ~~associated~~of ~~with~~our ~~prior~~real ~~year~~estate ~~property~~investment ~~damages~~portfolio, and andecreased ~~increase~~provisions offor ~~$0.1~~impairment, ~~million~~partially ofoffset ~~third-party~~by ~~debt~~increases ~~issuance~~in ~~costs~~depreciation ~~expensed~~expense, asinterest expense, general and administrative expense, property expense, and a ~~result~~decrease ofin ~~the~~gain ~~September~~on ~~2025~~sales ~~debt~~of ~~transactions~~real estate.

Net income (loss). Net income increased by $5.9 million to net income of $0.6 million for the three months ended September 30, 2025 from a net loss of $5.3 million for the three months ended September 30, 2024. Net income increased primarily due to additional rental revenues associated with the growth of our real estate investment portfolio, an increase in the net gain on the sales of real estate, and a decrease of provisions for impairment. These increases are partially offset by increases in interest expense, depreciation and amortization expense, and bonus and payroll-related expenses. 33

Table of Contents

Nine Months Ended September 30, 2025 Compared with Nine Months Ended September 30, 2024

The following table sets forth our operating results for the periods indicated (in thousands):

	Nine Months EndedSeptember 30,
	2025		2024
Revenues
Rental revenue (including reimbursable)	$	132,774	$	110,226
Interest income on loans receivable	9,485		8,458
Other revenue	245		—
Total revenues	142,504		118,684
Operating expenses
Property	13,589		12,578
General and administrative	15,772		15,266
Depreciation and amortization	63,818		56,522
Provisions for impairment	13,531		17,336
Transaction costs	139		201
Total operating expenses	106,849		101,903
Other (expense) income
Interest expense, net	(36,734)		(21,749)
Gain on sales of real estate, net	6,730		874
Loss on debt extinguishment	(46)		—
Other income (expense), net	46		(2,451)
Total other expense, net	(30,004)		(23,326)
Net income (loss) before income taxes	5,651		(6,545)
Income tax expense	(41)		(31)
Net income (loss)	$	5,610	$	(6,576)

Revenue. Revenue for the nine months ended September 30, 2025 increased by $23.8 million to $142.5 million from $118.7 million for the nine months ended September 30, 2024, which is attributed to an increase in the number of our operating leases and properties securing our mortgage loans. The increase includes additional cash rental receipts of $19.3 million, combined net increases of property expense reimbursements of $1.9 million, an increase of $1.4 million in straight-line rental revenue, an increase of $1.0 million related to interest income on mortgage loans receivable, and an increase of $0.2 million of other revenue related to settlement proceeds associated with a lease termination.

Total operating expenses. Total expenses increased by $4.9 million to $106.8 million for the nine months ended September 30, 2025 as compared to $101.9 million for the nine months ended September 30, 2024. The increase is primarily attributed to an increase in the number of operating properties, with the most significant increases being depreciation and amortization expense, property-specific reimbursable expenses, and payroll-related costs, offset by a decrease in employee severance and a decrease in provisions for impairment. Total operating expenses include the following:

•Property expenses. Property expenses increased by $1.0 million to $13.6 million for the nine months ended September 30, 2025 from $12.6 million for the nine months ended September 30, 2024. The increase is primarily attributed to the increase in the number of operating properties, including combined net increases of reimbursable property expenses of $0.6 million, of which $1.1 million were related to reimbursable property taxes, which were offset by decreases of $0.3 million and $0.2 million of reimbursable common area maintenance and reimbursable insurance, respectively, and combined net increases of non-reimbursable property expenses of $0.4 million, of which $0.3 million were related to property insurance.

•General and administrative expenses. General and administrative expenses increased by $0.5 million to $15.8 million for the nine months ended September 30, 2025 from $15.3 million for the nine months ended September 30, 2024. The increase is primarily due to an increase of $1.3 million of bonus expense, an increase of $0.3 million of stock-based compensation, and other net increases of $0.3 million, partially offset by a decrease of employee severance of $1.4 million. While our general and administrative expenses will continue to rise in some measure as our portfolio grows, we expect that such expenses, as a percentage of our portfolio ABR and total assets, will decrease over time due to operating efficiencies and economies of scale.

Table of Contents

•Depreciation and amortization. Depreciation and amortization expense increased by $7.3 million to $63.8 million for the nine months ended September 30, 2025 from $56.5 million for the nine months ended September 30, 2024. The increase in depreciation and amortization is proportionate to the increase in the size of the portfolio over the comparable period with associated increases primarily in building depreciation expense of $4.1 million, building improvements depreciation expense of $2.0 million, and in-place lease amortization expense of $1.2 million.

•Provisions for impairment. For the nine months ended September 30, 2025, we recorded provisions for impairment of $13.5 million on 34 properties and three mortgage loans receivable, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale, or disposed during the nine months ended September 30, 2025. Two properties were held for investment as of September 30, 2025. For the nine months ended September 30, 2024, we recorded provisions for impairment of $17.3 million on 40 properties, the majority of which were either previously classified as held-for-sale, newly classified as held-for-sale, or disposed during the nine months ended September 30, 2024. Nine properties were held for investment as of September 30, 2024. Property disposals relate to management’s continuous assessment of the Company’s portfolio in an effort to improve returns and manage risk exposure.

Interest expense, net. Interest expense increased by $15.0 million to $36.7 million for the nine months ended September 30, 2025 from $21.7 million for the nine months ended September 30, 2024. The increase is primarily attributable to an increase of $8.1 million of interest related to our term loans, of which $6.5 million, $0.8 million, and $0.7 million is related to our new 2030 Term Loan B, our $250.0 million senior unsecured term loan (the “2029 Term Loan”), and our $175.0 million senior unsecured term loan (the “2030 Term Loan A”), respectively. Additional increases are related to an increase of $5.1 million in amortization of deferred losses on interest rate swaps, an increase of $0.7 million of interest incurred under our Revolver, primarily due to an increase in average borrowings outstanding, an increase of $0.6 million of capitalized interest on our property developments, and an increase of $0.5 million in amortization of loan fees associated with the January 2025 debt transactions.

Gain on sales of real estate, net. Net gain on sales of real estate increased by $5.8 million to $6.7 million for the nine months ended September 30, 2025 from $0.9 million for the nine months ended September 30, 2024. For the nine months ended September 30, 2025, 60 properties were sold for a sales price, net of disposal costs, of $130.2 million. For the nine months ended September 30, 2024, 26 properties were sold for a sales price, net of disposal costs, of $55.6 million.

Other income (expense), net. Other income (expense), net decreased by $2.5 million to less than $0.1 million of other income for the nine months ended September 30, 2025 from $2.5 million of other expense for the nine months ended September 30, 2024. The net decrease in expense is primarily related to events that occurred during the nine months ended September 30, 2024, including a transfer fraud loss of $2.8 million, net of insurance recoveries, and $0.9 million of losses associated with property damages offset by $0.2 million of insurance recoveries, partially offset by $0.5 million of proceeds received from the settlement of a lease escrow agreement during the nine months ended September 30, 2024 and $0.4 million and $0.1 million of third-party debt issuance costs expensed as a result of the January 2025 and September 2025 debt transactions.

Net income (loss). Net income increased by $12.2 million to net income of $5.6 million for the nine months ended September 30, 2025 from a net loss of $6.6 million for the nine months ended September 30, 2024. Net income increased due to additional rental revenues associated with the growth of our real estate investment portfolio, in addition to increased interest income associated with our mortgage loans receivable, an increase in the net gain on the sales of real estate, a decrease in provisions for impairment, a decrease of employee severance, and the occurrence of a transfer fraud loss in the prior year. The increase in net income is partially offset by increases in interest expense and depreciation and amortization expense.

Liquidity and Capital Resources

Our primary capital requirements include funding property acquisitions and developments, ~~investments~~investing in mortgage loans receivable, making required debt interest payments, asand ~~well~~covering as working capital needs, operating expenses, and capital expenditures. Our capital resources primarily consist of cash from operations, sales of equity securities, and available borrowing facilities. As of ~~September~~March 3031, ~~2025~~2026, we had ~~$200.0~~total ~~million~~ outstanding ~~principal~~debt ~~amount~~of ~~under~~$1.2 ~~the~~billion, including $200.0 million ~~senior~~outstanding ~~unsecured~~principal ~~term~~amount ~~loan~~under (the “2028 Term Loan”), $250.0 million outstanding principal amount under the 2029 Term Loan, $175.0 million outstanding principal amount under the 2030 Term Loan A, $175.0 million outstanding principal amount under the 2030 Term Loan B, $200.0 million outstanding principal amount under the 2031 Term Loan, ~~and~~ $~~100~~150.0 million outstanding principal amount under the 2032 Term Loan, and $88.0 million outstanding on the Revolver. Additionally, as of ~~September~~March 3031, ~~2025~~2026, we had $40194.84 million and $3029.29 million of unsettled forward equity under our 2024 ATM Program and prior at-the-market equity program, respectively. As of ~~September~~March 3031, ~~2025~~2026, $~~271~~49.39 million of ~~remaining~~shares ~~gross~~of ~~proceeds~~our common stock were available for future issuances ~~of shares of our common stock~~ under the 2024 ATM Program~~, inclusive of unsettled shares under forward sale agreements~~. Lastly, we had $~~150~~81.57 million, $71.2 million, and $~~209~~228.74 million of unsettled forward equity under the January 2024, ~~and~~ July 2025, and February 2026 follow-on offering forward sale agreements, respectively, as of ~~September~~March 3031, ~~2025~~2026. As of March 31, 2026, we had an aggregate of 34,201,865 unsettled shares under forward sale agreements with a weighted-average net settlement price of $17.71.

37We believe the availability of proceeds from our debt, proceeds from the settlement of unsettled outstanding forward sale agreements, future issuances of shares of our common stock under our 2024 ATM Program, or subsequent at-the-market sale programs, as well as our cash flows from operations and available borrowing capacity under the Revolver, will be adequate to support our ongoing operations and to fund our debt service requirements, capital expenditures, and working capital requirements for at least the next 12 months. We anticipate funding our long-term capital needs through cash provided from operations, borrowings under our 2032 Term Loan, borrowings under our Revolver, and issuances of common stock.

Table of Contents

On January 15, 2025, we amended our PNC Credit Agreement to provide for a new $175.0 million 2030 Term Loan B and an upsized $500.0 million Revolver. The 2030 Term Loan B and the upsized Revolver initially mature in January 2029 and include, at our election, a one-year option to extend the maturity to January 2030. The 2030 Term Loan B was fully funded on the closing date and we have hedged the entire $175.0 million 2030 Term Loan B at an all-in fixed interest rate of 5.02% through January 2030. The Wells Fargo Credit Agreement was amended and restated to extend the maturity date of the existing $175.0 million 2030 Term Loan A from January 2027 to January 2029 with an option, at our election, to extend the maturity to January 2030.

On September 25, 2025, we entered into a PNC Term Loan Agreement to provide for a new $200.0 million 2031 Term Loan, which was fully funded on the closing date, and a $250.0 million 2032 Term Loan, of which $100.0 million was funded on the closing date and the remaining $150.0 million will be available until September 25, 2026. The 2031 Term Loan matures on March 25, 2031 and the 2032 Term Loan matures on September 24, 2032. We have hedged the entire $200.0 million 2031 Term Loan at an all-in fixed interest rate of 4.59% through March 2031. We have partially hedged $200.0 million of the 2032 Term Loan at an all-in fixed interest rate of 4.92% through September 2032, with the remaining $50.0 million of the 2032 Term Loan currently unhedged.

We believe the availability of proceeds from our debt, proceeds from the settlement of unsettled outstanding forward sale agreements, future issuances of shares of our common stock under our ATM program or subsequent at-the-market sale programs, as well as our cash flows from operations and available borrowing capacity under the Revolver, will be adequate to support our ongoing operations and to fund our debt service requirements, capital expenditures, and working capital requirements for at least the next 12 months. We anticipate funding our long-term capital needs through cash provided from operations, borrowings under our 2032 Term Loan, borrowings under our Revolver, and issuances of common stock.

Contractual Obligations and Commitments

As of ~~September~~March 3031, ~~2025~~2026, our contractual debt obligations primarily include the maturity of our 2028 Term Loan with the scheduled principal payment due on February 11, 2028, the maturity of our 2029 Term Loan with the scheduled principal payment due on July 3, 2026, the maturities of our 2030 Term Loan A, ~~and~~ 2030 Term Loan B, and Revolver with the scheduled principal payments due on January 15, 2029, the maturity of our 2031 Term Loan with the scheduled principal payment due on March 25, 2031, and the maturity of our 2032 Term Loan with the scheduled principal payment due on September 24, 2032. During the ~~nine~~three months ended ~~September 30~~March 31, ~~2025~~2026, we borrowed $~~199~~98.0 million ~~at a weighted average interest rate of 5.47%~~ and ~~also~~ repaid $~~438~~10.0 million on our Revolver.

3834

Table of Contents

The following table provides information with respect to our commitments as of ~~September~~March 3031, ~~2025~~2026 (in thousands):

	Payment Due by Period
	Total		From ~~October~~April 1, ~~2025~~2026 to December 31, ~~2025~~2026		~~2026~~2027 - ~~2027~~2028		~~2028~~2029 - ~~2029~~2030		Thereafter
Contractual Obligations
2028 Term Loan – Principal	$	200,000	$	—	$	—200,000	$	~~200,000~~—	$	—
2028 Term Loan – Variable interest (1)	1713,~~895~~377		15,~~906~~395		157,~~121~~982		~~868~~—		—
2029 Term Loan – Principal	250,000		—250,000		~~250,000~~—		—		—
2029 Term Loan – Variable interest (1)	93,~~236~~017		3,~~079~~017		~~6,157~~—		—		—
2030 Term Loan A – Principal	175,000		—		—		175,000		—
2030 Term Loan A – Variable interest (1)	2016,~~437~~365		14,~~564~~412		1211,~~412~~712		~~6,461~~241		—
2030 Term Loan B – Principal	175,000		—		—		175,000		—
2030 Term Loan B – Variable interest (1)	2823,~~953~~591		26,~~216~~360		1716,~~584~~884		~~9,153~~347		—
2031 Term Loan – Principal	200,000		—		—		—		200,000
2031 Term Loan – Variable interest (1)	5043,~~296~~728		26,~~312~~611		1817,~~349~~549		1817,~~349~~549		112,~~286~~019
2032 Term Loan – Principal	~~100~~150,000		—		—		—		~~100~~150,000
2032 Term Loan – Variable interest (1)	3445,~~541~~308		15,~~247~~263		913,~~891~~972		913,~~891~~972		1312,~~512~~101
Ticking Fee (2)	~~225~~98		598		~~220~~—		—		—
Facility Fee (3)	2,470		189		1,500		781		—
Revolver – Borrowings	88,000		—		—		88,000		—
Mortgage Note – Principal	8,084		43		8,041		—		—
Revolver – Variable interest	11,017		2,970		7,885		162		—
Mortgage Note – Interest	772		91		681		—		—
Facility Fee (3)	2,794		753		2,000		41		—
Property development under contract	6,269		1,740		4,529		—		—
Mortgage Note – Principal	7,999		134		7,865		—		—
Additional principal under mortgage loans receivable	11,403		4,778		6,625		—		—
Mortgage Note – Interest	591		269		322		—		—
Tenant improvement allowances	6,339		3,599		2,740		—		—
Property development under contract	22,313		10,547		11,766		—		—
Corporate office lease obligations	4,795		161		1,323		1,396		1,915
Additional principal under mortgage loans receivable	6,422		5,236		1,186		—		—
Total	$	1,301,715	$	22,930	$	355,173	$	596,899	$	326,713
Tenant improvement allowances	8,254		4,165		4,089		—		—
Corporate office lease obligations	4,473		491		1,359		1,434		1,189
Total	$	1,447,347	$	305,721	$	304,571	$	471,746	$	365,309

(1) We have various interest rate derivative contracts to fix the variable base interest rate (SOFR) on our term loans. Accordingly, the projected interest rate obligations for the variable rate term loans are based on the weighted-average hedged fixed rates, plus the applicable margins. See “Note 6 – Debt” and “Note 7 – Derivative Financial Instruments” for further discussion on our debt and interest rate hedges.

(2) We are subject to a ticking fee of 0.20% on the undrawn amount under our 2032 Term Loan.

(3) We are subject to a facility fee of 0.1520% on our Revolver.

In August 2021, we entered into a lease agreement related to our corporate office space, which is classified as an operating lease. We began operating out of the office in February 2022. The lease has a remaining noncancellable term of 6.83 years that expires on July 31, 2032 and is renewable at our option for two additional periods of five years. Annual rent expense, excluding operating expenses, is approximately $0.5 million during the initial term.

Additionally, in the normal course of business, we enter into various types of commitments to purchase real estate properties, fund development projects, or extend funds under mortgage loans receivable. These commitments are generally subject to our customary due diligence process and, accordingly, a number of specific conditions must be met before we are obligated to purchase or extend funding. As of ~~September~~March 3031, ~~2025~~2026, we had commitments to fund property developments, ~~and~~ extend funds under mortgage loans receivable, and commitments to fund tenant improvement allowances totaling $622.3 million, $6.4 million, and $118.4 3 million, respectively. Commitments to fund property developments are expected to occur over the next nine months, ~~which~~commitments isto fund mortgage loans receivable are expected to beoccur ~~funded~~over ~~through~~the next 18 months, and commitments to fund tenant improvement allowances are expected to occur over the ~~end~~next oftwo ~~2026~~years.

Debt

See discussion of our debt and interest rate hedges included in “Note 6 – Debt” and “Note 7 – Derivative Financial Instruments” in “Item 1 – Financial Statements (unaudited).”

3935

Table of Contents

Historical Cash Flow Information

~~Nine~~Three Months Ended ~~September~~March 3031, ~~2025~~2026 Compared with ~~Nine~~Three Months Ended ~~September~~March 3031, ~~2024~~2025

	Nine Months EndedSeptember 30,
	Three Months EndedMarch 31,
	2025		2024
	2026		2025
(In thousands)	(Unaudited)
Net cash provided by (used in):
Operating activities	$	8026,~~701~~312	$	6222,~~128~~091
Investing activities	(~~239~~211,~~508~~692)		(~~319~~48,~~379~~308)
Financing activities	~~197~~181,~~811~~971		~~256~~26,~~072~~102

Cash Flows Provided By Operating Activities. Net cash provided by operating activities increased by $184.62 million for the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 compared to the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025. The increase was largely attributed to the increase in the size of our real estate investment portfolio with an increase in rental receipts of $199.35 million, ~~additional interest received under our mortgage loans receivable, and changes in working capital accounts,~~ partially offset by an increase in cash paid for interest of $92.17 million, ~~and~~ an increase in operating expenses paid associated with our larger portfolio, and changes in working capital accounts.

Cash Flows Used In Investing Activities. Net cash used in investing activities ~~decreased~~increased by $79163.94 million for the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 compared to the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025. The ~~decrease~~increase was primarily due to an increase in acquisitions of ~~$78.9~~real ~~million~~estate ~~and~~of $10156.52 million, ofa ~~proceeds~~decrease ~~received~~in proceeds from the sale of real estate of $28.2 million, and ~~mortgage~~an ~~loans~~increase ~~receivable,~~in ~~respectively,~~real aestate ~~decrease~~development and improvements of $332.39 million, inpartially ~~real~~offset ~~estate~~by ~~development~~a ~~and~~decrease ~~improvements,~~in anearnest ~~increase~~money deposits of $136.45 million, an increase in principal collections on mortgage loans receivable, ~~and a decrease~~ of $76.54 million, an increase in ~~earnest~~proceeds ~~money~~received ~~deposits,~~from ~~partially~~the ~~offset~~sale byof anmortgage ~~increase~~loans receivable of $625.96 million, ~~in acquisitions of real estate~~ and ana ~~increase~~decrease in cash invested in mortgage loans receivable of $0.5.4 million.

Cash Flows Provided By Financing Activities. Net cash provided by financing activities ~~decreased~~increased by $58155.39 million for the ~~nine~~three months ended ~~September~~March 3031, ~~2025~~2026 compared to the ~~nine~~three months ended ~~September~~March 3031, ~~2024~~2025. The ~~decrease~~increase was primarily attributed to ana ~~increase~~decrease in net repayments of $~~309~~212.05 million under our Revolver, ~~and~~an increase of $~~107~~67.18 million of ~~less~~ proceeds received ~~due~~from tothe ~~fewer~~issuance ~~issuances~~ of common stock inunder ~~connection~~our ~~with~~January ~~our~~2024 ~~ATM~~Follow-On ~~Programs~~Offering, and ~~forward~~a ~~sale agreements. Additional items contributing to the~~ decrease ~~are~~in andeferred ~~increase~~financing costs of $126.03 million, inpartially ~~deferred~~offset ~~financing~~by ~~costs~~a ~~and~~decrease ~~an increase~~ in ~~payments~~net ofterm ~~common~~loan ~~stock~~proceeds ~~dividends~~ of $6125.0 million., ~~The decrease is partially offset by~~ an increase in ~~net~~payments ~~term~~of ~~loan~~common ~~proceeds~~stock dividends of $~~375~~4.02 million, and aan ~~decrease~~increase in the repurchase of common stock for tax withholding obligations of $01.61 million.

Income Taxes

We have elected to be treated and qualify as a REIT for U.S. federal income tax purposes. To qualify as a REIT, we must meet certain organizational, income, asset, and distribution tests. Accordingly, we will generally not be subject to corporate U.S. federal or state income tax to the extent that we make qualifying distributions of all of our taxable income to our stockholders and provided we satisfy on a continuing basis, through actual investment and operating results, the REIT requirements, including certain asset, income, distribution, and share ownership tests. We intend to make sufficient distributions during ~~2025~~2026 to receive a full dividends paid deduction.

We maintain a taxable REIT subsidiary (“TRS”) which may be subject to U.S. federal, state, and local income taxes on its taxable income. In general, our TRS may perform services for our tenants, hold assets that we cannot hold directly, and may engage in any real estate or non-real estate-related business.

We recognize franchise and other state and local tax expenses in general and administrative expenses and federal income tax in income tax expense in the accompanying condensed consolidated statements of operations and comprehensive income (loss).

Recent Accounting Pronouncements

A discussion of recent accounting pronouncements and their possible effects on our condensed consolidated financial statements is included in “Note 2 – Summary of Significant Accounting Policies” in “Item 1 – Financial Statements (unaudited).”

4036

Table of Contents

Critical Accounting Policies and Estimates

Our accounting policies have been established to conform with U.S. generally accepted accounting principles (“GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires us to use judgment in the application of accounting policies, including making estimates and assumptions. These judgments affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Management believes that we have made these estimates and assumptions in an appropriate manner and in a way that accurately reflects our financial condition. We continually test and evaluate these estimates and assumptions using our historical knowledge of the business, as well as other factors, to ensure that they are reasonable for reporting purposes. However, actual results may differ from these estimates and assumptions. If our judgment or interpretation of the facts and circumstances relating to the various transactions had been different, it is possible that different accounting policies would have been applied, thus resulting in a different presentation of the financial statements. Additionally, other companies may utilize different estimates that may impact comparability of our results of operations to those of companies in similar businesses. A summary of our critical accounting policies is included in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, ~~2024~~2025, which is accessible on the SEC’s website at www.sec.gov. There have been no material changes to these policies during the periods covered by this quarterly report.

Non-GAAP Financial Measures

Our reported results are presented in accordance with GAAP. We also disclose the following non-GAAP financial measures: Funds From Operations (“FFO”), Core FFO, Adjusted FFO (“AFFO”), earnings before interest expense, income tax expense, and depreciation and amortization (“EBITDA”), EBITDA further adjusted to exclude gains (or losses) from the sales of depreciable property and real estate impairment losses (“EBITDAre”), Adjusted EBITDAre, Annualized Adjusted EBITDAre, Net Debt, Adjusted Net Debt, property-level net operating income (“Property-Level NOI”), property-level cash net operating income (“Property-Level Cash NOI”), and property-level cash net operating income estimated run rate (“Property-Level Cash NOI - Estimated Run Rate”), all of which are detailed below. We believe these non-GAAP financial measures are industry measures used by analysts and investors to compare the operating performance of REITs.

FFO, Core FFO, and AFFO

The National Association of Real Estate Investment Trusts (“NAREIT”), an industry trade group, has promulgated a widely accepted non-GAAP financial measure of operating performance known as FFO. Our FFO is net income in accordance with GAAP, excluding gains (or losses) resulting from dispositions of properties, plus depreciation and amortization and impairment charges on depreciable real property.

Core FFO is a non-GAAP financial measure defined as FFO adjusted to remove the effect of unusual and non-recurring items that are not expected to impact our operating performance or operations on an ongoing basis. These include non-recurring executive transition costs, severance and related charges, other non-recurring losses (gains), ~~and~~ debt related transaction costs, and other losses (gains).

AFFO is a non-GAAP financial measure defined as Core FFO adjusted for GAAP net income related to non-cash revenues and expenses, such as straight-line rent, amortization of above- and below-market lease-related intangibles, amortization of lease incentives, capitalized interest expense and earned development interest, non-cash interest expense, non-cash compensation expense, amortization of deferred financing costs, amortization of above/below-market assumed debt, and amortization of loan origination costs.

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. In fact, real estate values historically have risen or fallen with market conditions. FFO is intended to be a standard supplemental measure of operating performance that excludes historical cost depreciation and valuation adjustments from net income. We consider FFO to be useful in evaluating potential property acquisitions and measuring operating performance.

We further consider FFO, Core FFO, and AFFO to be useful in determining funds available for payment of distributions. FFO, Core FFO, and AFFO do not represent net income or cash flows from operations as defined by GAAP. You should not consider FFO, Core FFO, and AFFO to be alternatives to net income as a reliable measure of our operating performance nor should you consider FFO, Core FFO, and AFFO to be alternatives to cash flows from operating, investing, or financing activities (as defined by GAAP) as measures of liquidity.

FFO, Core FFO, and AFFO do not measure whether cash flow is sufficient to fund our cash needs, including principal amortization, capital improvements, and distributions to stockholders. FFO, Core FFO, and AFFO do not represent cash flows 37

Table of Contents

FFO, Core FFO, and AFFO do not measure whether cash flow is sufficient to fund our cash needs, including debt service obligations, capital improvements, and distributions to stockholders. FFO, Core FFO, and AFFO do not represent cash flows from operating, investing, or financing activities as defined by GAAP. Further, FFO, Core FFO, and AFFO as disclosed by other REITs might not be comparable to our calculations of FFO, Core FFO, and AFFO.

The following table sets forth a reconciliation of FFO, Core FFO, and AFFO for the periods presented to net income ~~(loss)~~ before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
	(Unaudited)				~~(Unaudited)~~
Net income (loss)	$	621	$	(5,322)	$	5,610	$	(6,576)
Net income	$	5,711	$	1,700
Depreciation and amortization of real estate	2124,~~315~~387		20,~~360~~850		~~63,598~~		~~56,286~~
Provisions for impairment	41,~~134~~488		93,~~838~~616		~~12,173~~		~~17,336~~
(Gain) loss on sales of real estate, net	(1,122)		132		(6,730)		(874)
Gain on sales of real estate, net	(119)		(2,075)
FFO	2431,~~948~~467		2524,~~008~~091		~~74,651~~		~~66,172~~
Adjustments:
Non-recurring executive transition costs, severance, and related charges	1—		1476		80		~~1,495~~
Debt related transaction costs	92		—		495		—
Loss on debt extinguishment and other related costs	—		403
Other non-recurring loss (gain), net	1,314		(115)		1,314		3,077
Other loss	574		—
Core FFO	2632,~~355~~041		24,~~907~~570		~~76,540~~		~~70,744~~
Adjustments:
Straight-line rent adjustments	(12,~~126~~153)		(~~749~~954)		~~(3,263)~~		~~(1,829)~~
Amortization of deferred financing costs	~~756~~971		~~558~~664		~~2,164~~		~~1,673~~
Amortization of above/below-market assumed debt	29		29		86		86
Amortization of loan origination costs and discounts	(~~147~~133)		(~~265~~77)		~~(197)~~		~~(242)~~
Amortization of lease-related intangibles	~~(35)~~47		(~~170~~70)		~~(110)~~		~~(363)~~
Earned development interest	36116		~~259~~43		~~118~~		~~962~~
Capitalized interest expense	(2488)		(~~130~~50)		~~(112)~~		~~(709)~~
Non-cash interest expense (income)	721		(990)		2,138		(2,948)
Non-cash interest expense	705		705
Non-cash compensation expense	1,~~484~~689		1,~~376~~388		~~4,393~~		~~4,128~~
AFFO	$	2833,~~049~~224	$	2426,~~825~~248	$	~~81,757~~	$	~~71,502~~

EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre

We compute EBITDA as earnings before interest expense, income tax expense, and depreciation and amortization. In 2017, NAREIT issued a white paper recommending that companies that report EBITDA also report EBITDAre. We compute EBITDAre in accordance with the definition adopted by NAREIT. NAREIT defines EBITDAre as EBITDA (as defined above) excluding gains (or losses) from the sales of depreciable property and impairment charges on depreciable real property.

Adjusted EBITDAre is a non-GAAP financial measure defined as EBITDAre further adjusted to exclude straight-line rent, non-cash compensation expense, non-recurring executive transition costs, severance and related charges, debt related transaction costs, transaction costs, other non-recurring loss (gain), net, other non-recurring expenses (income) including lease termination fees, as well as adjustments for construction in process and for intraquarter activities. Annualized Adjusted EBITDAre is Adjusted EBITDAre multiplied by four.

We present EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre as they are measures commonly used in our industry. We believe that these measures are useful to investors and analysts because they provide supplemental information concerning our operating performance, exclusive of certain non-cash items and other costs. We use EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre as measures of our operating performance and not as measures of liquidity.

4238

Table of Contents

EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre do not include all items of revenue and expense included in net income, they do not represent cash generated from operating activities and they are not necessarily indicative of cash available to fund cash requirements; accordingly, they should not be considered alternatives to net income as a performance measure or cash flows from operations as a liquidity measure and should be considered in addition to, and not in lieu of, GAAP financial measures. Additionally, our computation of EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre may differ from the methodology for calculating these metrics used by other equity REITs and, therefore, may not be comparable to similarly titled measures reported by other equity REITs.

The following table sets forth a reconciliation of EBITDA and EBITDAre for the periods presented to net income ~~(loss)~~ before allocation to noncontrolling interests, as computed in accordance with GAAP (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	Three Months Ended March 31,
	2025		2024		2025		2024
	2026		2025
	(Unaudited)				~~(Unaudited)~~
Net income (loss)	$	621	$	(5,322)	$	5,610	$	(6,576)
Net income	$	5,711	$	1,700
Depreciation and amortization of real estate	2124,~~315~~387		20,~~360~~850		~~63,598~~		~~56,286~~
Amortization of lease-related intangibles	~~(35)~~47		(~~170~~70)		~~(110)~~		~~(363)~~
Non-real estate depreciation and amortization	7476		7873		~~220~~		~~236~~
Interest expense, net	1214,~~636~~266		711,~~965~~460		~~36,734~~		~~21,749~~
Income tax expense	1214		216		41		31
Amortization of loan origination costs and discounts	(~~147~~133)		(~~265~~77)		~~(197)~~		~~(242)~~
EBITDA	3444,~~476~~368		2233,~~648~~952		~~105,896~~		~~71,121~~
Adjustments:
Provisions for impairment	41,~~134~~488		93,~~838~~616		~~12,173~~		~~17,336~~
(Gain) loss on sales of real estate, net	(1,122)		132		(6,730)		(874)
Gain on sales of real estate, net	(119)		(2,075)
EBITDAre	$	3745,~~488~~737	$	3235,~~618~~493	$	~~111,339~~	$	~~87,583~~

4339

Table of Contents

The following table sets forth a reconciliation of EBITDA, EBITDAre, Adjusted EBITDAre, and Annualized Adjusted EBITDAre for the period presented to net income before allocation to noncontrolling interests, as computed in accordance with GAAP (~~dollars~~ in thousands):

	Three Months Ended September 30, 2025
	Three Months Ended March 31, 2026
	(Unaudited)
Net income	$	~~621~~5,711
Depreciation and amortization of real estate	2124,~~315~~387
Amortization of lease-related intangibles	~~(35)~~47
Non-real estate depreciation and amortization	7476
Interest expense, net	1214,~~636~~266
Income tax expense	1214
Amortization of loan origination costs and discounts	(~~147~~133)
EBITDA	3444,~~476~~368
Adjustments:
Provisions for impairment	41,~~134~~488
Gain on sales of real estate, net	(~~1,122~~119)
EBITDAre	3745,~~488~~737
Adjustments:
Straight-line rent adjustments	(12,~~126~~153)
Debt related transaction costs	92
Other loss	574
Non-recurring executive transition costs, severance, and related charges	1
Other income, net	(31)
Other non-recurring loss, net	1,314
Transaction costs, net	(60)
Transaction costs	19
Non-cash compensation expense	1,689
Non-cash compensation expense	1,484
Adjustment for construction in process (1)	208
Adjustment for construction in process (1)	32
Adjustment for intraquarter investment activities (2)	2,964
Adjustment for intraquarter investment activities (2)	2,474
Adjusted EBITDAre	$	48,928
Adjusted EBITDAre	41,778
Annualized Adjusted EBITDAre (3)	$	195,712
Annualized Adjusted EBITDAre (3)	$	167,112
Adjusted Net Debt / Annualized Adjusted EBITDAre	6.3x
Net Debt / Annualized Adjusted EBITDAre	6.3x
Adjusted Net Debt / Annualized Adjusted EBITDAre	3.2x
Adjusted Net Debt / Annualized Adjusted EBITDAre	3.7x
Pro Forma Adjusted Net Debt / Annualized Adjusted EBITDAre	3.2x
Pro Forma Adjusted Net Debt / Annualized Adjusted EBITDAre	3.6x

(1) Adjustment reflects the estimated cash yield on developments in process as of ~~September~~March 3031, ~~2025~~2026.

(2) Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments completed during the three months ended ~~September 30~~March 31, ~~2025~~2026, had occurred on ~~July~~January 1, ~~2025~~2026.

(3) We calculate Annualized Adjusted EBITDAre by multiplying Adjusted EBITDAre by four.

Net Debt, Adjusted Net Debt, and Pro Forma Adjusted Net Debt

We calculate Net Debt as the principal amount of our total debt outstanding, excluding deferred financing costs, net discounts, and debt issuance costs, less cash, cash equivalents, and restricted cash available for future investment.

We then adjust Net Debt by the net value of unsettled forward equity as of period end to derive Adjusted Net Debt. Further, we adjust Adjusted Net Debt by the value of any unsettled forward equity and at-the-market sales occurring subsequent to the period to derive Pro Forma Adjusted Net Debt.

We believe excluding cash, cash equivalents, and restricted cash available for future investment from the principal amount of our total debt outstanding, together with the exclusion of the net value of unsettled forward equity as of period end and the net value of unsettled forward equity and at-the-market sales subsequent to the period, all of which could be used to repay debt, provides a useful estimate of the net contractual amount of borrowed capital to be repaid. We believe these adjustments are additional beneficial disclosures to investors and analysts.

4440

Table of Contents

The following table reconciles the principal amount of total debt to Net Debt, Adjusted Net Debt, and Pro Forma Adjusted Net Debt (in thousands):

	As of
	September 30, 2025
	March 31, 2026
Principal amount of total debt	$	1,108,084
	(Unaudited)
Less: Cash, cash equivalents, and restricted cash	(53,324)
Principal amount of total debt	$	1,245,999
Net Debt	1,054,760
Less: Cash, cash equivalents, and restricted cash	(11,058)
Less: Net value of unsettled forward equity (1)	(431,246)
Net Debt	1,234,941
Adjusted Net Debt	623,514
Less: Net value of unsettled forward equity (1)	(605,622)
Less: Subsequent ATM sales (2)	(29,682)
Adjusted Net Debt	629,319
Pro Forma Adjusted Net Debt	$	593,832
Less: Subsequent ATM sales (2)	(5,952)
Pro Forma Adjusted Net Debt	$	623,367

(1) There were 2534,~~393~~201,~~242~~865 unsettled shares under forward ~~equity~~sale ~~contracts~~agreements as of ~~September~~March 3031, ~~2025~~2026 atwith ~~the~~a ~~available~~ weighted-average net settlement price of $1617.9871.

(2) There were 1307,~~556,592~~984 unsettled shares under new forward equity contracts executed subsequent to the period atwith ~~the~~a ~~available~~ weighted-average net settlement price of $1819.1233. ~~Additionally, there were 82,500 shares of common stock issued under the ATM program at a net settlement price of $17.96 per share.~~

Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate

Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate are non-GAAP financial measures which we use to assess our operating results. We compute Property-Level NOI as net income (computed in accordance with GAAP), excluding general and administrative expenses, interest expense, net, income tax expense, amortization of loan origination costs and discounts, transaction costs, depreciation and amortization, gains (or losses) on sales of depreciable property, real estate impairment losses, interest income on mortgage loans receivable, debt related transaction costs, and other expense (income), net, including lease termination fees. We further adjust Property-Level NOI for non-cash revenue components of straight-line rent and amortization of lease-intangibles to derive Property-Level Cash NOI. We further adjust Property-Level Cash NOI for intraquarter acquisitions, dispositions, and completed development to derive Property-Level Cash NOI - Estimated Run Rate. We believe Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate provide useful and relevant information because they reflect only those income and expense items that are incurred at the property level and present such items on an unlevered basis.

Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate are not measurements of financial performance under GAAP and may not be comparable to similarly titled measures of other companies. You should not consider our measures as alternatives to net income or cash flows from operating activities determined in accordance with GAAP.

4541

Table of Contents

The following table sets forth a reconciliation of Property-Level NOI, Property-Level Cash NOI, and Property-Level Cash NOI - Estimated Run Rate for the period presented (in thousands):

	Three Months Ended September 30, 2025
	Three Months Ended March 31, 2026
	(Unaudited)
Net income	$	~~621~~5,711
General and administrative expense	5,128
General and administrative	5,755
Depreciation and amortization	2124,~~389~~463
Provisions for impairment	52,~~493~~062
Transaction costs	19
Transaction costs, net	(60)
Interest expense, net	1214,~~636~~266
Gain on sales of real estate, net	(~~1,122~~119)
Income tax expense	1214
Amortization of loan origination costs and discounts	(~~147~~133)
Interest income on mortgage loans receivable	(3,~~282~~035)
Other income, net	(~~170~~465)
Property-Level NOI	4048,~~577~~459
Straight-line rent adjustments	(12,~~126~~153)
Amortization of lease-related intangibles	~~(35)~~47
Property-Level Cash NOI	$	3946,~~416~~353
Adjustment for intraquarter acquisitions, dispositions, and completed development (1)	23,~~691~~117
Property-Level Cash NOI - Estimated Run Rate	$	42,107
Property-Level Cash NOI Estimated Run Rate	$	49,470

(1) Adjustment assumes all re-leasing activity, investments in and dispositions of real estate, including developments completed during the three months ended ~~September 30~~March 31, ~~2025~~2026, had occurred on ~~July~~January 1, ~~2025~~2026.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Our future income, cash flows, and fair value relevant to our financial instruments depend upon prevailing market interest rates. Market risk refers to the risk of loss from adverse changes in market prices and interest rates. Based upon the nature of our operations, the principal market risk to which we are exposed is the risk related to interest rate fluctuations. As of ~~September~~March 3031, ~~2025~~2026, we had total indebtedness of $200.0 million under the 2028 Term Loan, $250.0 million under the 2029 Term Loan, $175.0 million under the 2030 Term Loan A, $175.0 million under the 2030 Term Loan B, $200.0 million under the 2031 Term Loan, ~~and~~ $~~100~~150.0 million under the 2032 Term Loan, and $88.0 million under the Revolver, all of which are floating rate debt with a variable interest rate. For the three ~~and nine~~ months ended ~~September 30~~March 31, ~~2025~~2026, we had average daily outstanding borrowings on our Revolver of $~~111~~3.~~7 million~~0 ~~and $116.5~~ million~~, respectively~~.

We have entered into interest rate derivative contracts in order to hedge our market risk associated with ~~the~~our term loans. The 2028 Term Loan, 2029 Term Loan, 2030 Term Loan B, 2031 Term Loan, and 2032 Term Loan have interest rate hedges that coincide with the extended maturity dates of the loans. The 2030 Term Loan A interest rate ~~hedge~~hedges ~~matures~~mature on January 23, 2027. The interest rate derivative contracts convert the variable rate debt on our term loans to a fixed interest rate (as further described in “Note 7 – Derivative Financial Instruments” in our condensed consolidated financial statements).

Additionally, we will occasionally fund acquisitions through the use of our Revolver which, as of ~~September~~March 3031, ~~2025~~2026, bore an interest rate determined by either (i) SOFR, plus a margin ranging from 10.00725% to 1.4540%, based on ~~our~~the Company’s current credit rating and consolidated total leverage ratio, or (ii) a Base Rate (as defined in the PNC Credit Agreement), plus a margin ranging from 0.00% to 0.4540%, based on ~~our~~the Company’s current credit rating and consolidated total leverage ratio. Many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, and other factors that are beyond our control contribute to our interest rate risk. Based on the results of our sensitivity analysis and daily outstanding borrowings on the Revolver during ~~2025~~2026, which assumes a 1% adverse change in the interest rate as of ~~September~~March 3031, ~~2025~~2026, the estimated market risk exposure was ~~approximately~~less than $10.2 1 million.

4642

Table of Contents

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures.

At the end of the period covered by this report, the Company conducted an evaluation, under the supervision and with the participation of its principal executive officer and principal financial officer, of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Company’s principal executive officer and principal financial officer concluded that its disclosure controls and procedures were effective as of ~~September~~March 3031, ~~2025~~2026 to ensure that information required to be disclosed by us in reports that the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

Changes in Internal Control over Financial Reporting.

During the period covered by this report, there were no changes to the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation described above that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

4743

Table of Contents

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we may be party to various lawsuits, claims, and other legal proceedings that arise in the ordinary course of our business. We are not currently subject to any material lawsuits, claims, or other legal proceedings.

Item 1A. Risk Factors

For a discussion of the most significant factors that may adversely affect us, see the information under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, ~~2024~~2025, which is accessible on the SEC’s website at www.sec.gov. There have been no material changes to the risk factors disclosed in the Annual Report. These risk factors may not describe every risk facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, and results of operations.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Unregistered Sales of Equity Securities ~~and Use of Proceeds~~

~~None~~Subject to the satisfaction of certain conditions, holders of OP Units in the Operating Partnership may tender their OP Units for redemption by the Operating Partnership in exchange for cash equal to the market price of shares of our common stock at the time of redemption or, at our election, for shares of common stock on a one-for-one basis. During the three months ended March 31, 2026, we elected to satisfy certain redemption requests by issuing a total of 9,965 shares of common stock in reliance upon an exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended.

Company Stock Repurchases

None.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

~~Not~~Rule ~~applicable.~~10b5-1 Trading Arrangements

48None of our directors or executive officers (as defined in Rule 16a1(f) under the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement or adopted or terminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the quarter ended March 31, 2026.

Table of Contents

Item 6. Exhibits

Exhibit No.						Description
3.1						Conformed Articles of Amendment and Restatement of NETSTREIT Corp. (incorporated by reference to Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022).
3.2						Amended and Restated Bylaws of NETSTREIT Corp. (incorporated by reference to Exhibit 3.2 to the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2022).
10.1*#						First Amendment to Second Amended and Restated Credit Agreement, dated as of September 25, 2025, by and among NETSTREIT, L.P., NETSTREIT Corp., the several institutions party thereto, as lenders, and Wells Fargo Bank, National Association, as Administrative Agent.
10.1*						Second Amended and Restated Agreement of Limited Partnership of NETSTREIT, L.P.
10.2†*						Form of Basic LTIP Unit Award Agreement.
10.3†*						Form of Performance LTIP Unit Award Agreement.
31.1*						Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2*						Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1*						Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.1**						Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2*						Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2**						Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS**						XBRL Instance Document.
101.INS***						XBRL Instance Document.
101.SCH***						XBRL Taxonomy Extension Schema Document.
101.CAL***						XBRL Taxonomy Extension Calculation Linkbase Document.
101.LAB***						XBRL Taxonomy Extension Label Linkbase Document.
101.PRE***						XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEF***						XBRL Taxonomy Extension Definition Linkbase Document.
104**						Cover Page Interactive Data File.
104***						Cover Page Interactive Data File (embedded within the Inline XBRL document).

*						Filed herewith.
**						The XBRL Instance Document and Cover Page Interactive Data File do not appear in the Interactive Data File because their XBRL tags are embedded within the Inline XBRL document.
***						Submitted electronically with the report.
#						Certain of the exhibits and schedules to this exhibit have been omitted in accordance with Regulation S-K Item 601(a)(5). The Company agrees to furnish a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.


*						Filed herewith.
**						Furnished herewith.
***						Submitted electronically with the report.
†						Management contract or compensatory plan or arrangement.

4945

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

NETSTREIT Corp.

October 27, 2025

/s/ MARK MANHEIMER

April 20, 2026

/s/ MARK MANHEIMER

Date

Mark Manheimer

President, Chief Executive Officer, Secretary and Director

(Principal Executive Officer)

October 27, 2025

/s/ DANIEL DONLAN

April 20, 2026

/s/ DANIEL DONLAN

Date

Daniel Donlan

Chief Financial Officer and Treasurer

(Principal Financial Officer)

October 27, 2025

/s/ SOFIA CHERNYLO

April 20, 2026

/s/ SOFIA CHERNYLO

Date

Sofia Chernylo

Senior Vice President and Chief Accounting Officer

(Principal Accounting Officer)

5046

Filing Compare · NETSTREIT Corp.